<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002013.pub3" GROUP_ID="ANAESTH" ID="739299091117220674" MERGED_FROM="" MODIFIED="2014-03-14 10:51:07 +0000" MODIFIED_BY="Jane Cracknell" REVIEW_NO="001" REVMAN_SUB_VERSION="5.2.8 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="14.0">
<COVER_SHEET MODIFIED="2014-03-14 10:51:07 +0000" MODIFIED_BY="Jane Cracknell">
<TITLE>Pulse oximetry for perioperative monitoring</TITLE>
<CONTACT MODIFIED="2014-03-14 10:51:07 +0000" MODIFIED_BY="Jane Cracknell"><PERSON ID="55580854841860714164110824165304" ROLE="AUTHOR"><FIRST_NAME>Amanda</FIRST_NAME><LAST_NAME>Nicholson</LAST_NAME><EMAIL_1>amanda.nicholson@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Liverpool Reviews and Implementation Group</DEPARTMENT><ORGANISATION>University of Liverpool</ORGANISATION><ADDRESS_1>Second Floor</ADDRESS_1><ADDRESS_2>Whelan Building, The Quadrangle, Brownlow Hill</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L69 3GB</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-03-14 10:51:07 +0000" MODIFIED_BY="Jane Cracknell"><PERSON ID="6521" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tom</FIRST_NAME><LAST_NAME>Pedersen</LAST_NAME><POSITION>Director of the Head and Orthopaedic Center</POSITION><EMAIL_1>doctp@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>Head and Orthopaedic Center</DEPARTMENT><ORGANISATION>Rigshospitalet</ORGANISATION><ADDRESS_1>HOC 2101, Rigshospitalet</ADDRESS_1><ADDRESS_2>University of Copenhagen,Blegdamsvej 9</ADDRESS_2><CITY>Copenhagen</CITY><ZIP>DK-2100</ZIP><COUNTRY CODE="DK">Denmark</COUNTRY><PHONE_1>+45 35 45 30 50</PHONE_1><FAX_1>+45 35 45 32 45</FAX_1></ADDRESS></PERSON><PERSON ID="55580854841860714164110824165304" ROLE="AUTHOR"><FIRST_NAME>Amanda</FIRST_NAME><LAST_NAME>Nicholson</LAST_NAME><EMAIL_1>amanda.nicholson@liverpool.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Liverpool Reviews and Implementation Group</DEPARTMENT><ORGANISATION>University of Liverpool</ORGANISATION><ADDRESS_1>Second Floor</ADDRESS_1><ADDRESS_2>Whelan Building, The Quadrangle, Brownlow Hill</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L69 3GB</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="7CB0440382E26AA20029B854204A24F5" ROLE="AUTHOR"><FIRST_NAME>Karen</FIRST_NAME><LAST_NAME>Hovhannisyan</LAST_NAME><POSITION>Trials Search Co-ordinator</POSITION><EMAIL_1>karen.hovhannisyan@gmail.com</EMAIL_1><URL>http://carg.cochrane.org</URL><MOBILE_PHONE>0046 73 9909534</MOBILE_PHONE><ADDRESS><DEPARTMENT>The Cochrane Anaesthesia Review Group</DEPARTMENT><ORGANISATION>Rigshospitalet</ORGANISATION><ADDRESS_1>Blegdamsvej 9,</ADDRESS_1><ADDRESS_2>Afsnit 5211, rum 1204</ADDRESS_2><CITY>Copenhagen</CITY><ZIP>2100</ZIP><COUNTRY CODE="DK">Denmark</COUNTRY><PHONE_1>+45 35457423</PHONE_1><FAX_1>+45 35457454</FAX_1></ADDRESS></PERSON><PERSON ID="EB70DC0182E26AA2017A33F280B4E311" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Ann  Merete</FIRST_NAME><LAST_NAME>Møller</LAST_NAME><SUFFIX>MD, PhD</SUFFIX><POSITION>Co-ordinating Editor</POSITION><EMAIL_1>docamm@yahoo.com</EMAIL_1><EMAIL_2>annmo@heh.regionh.dk</EMAIL_2><MOBILE_PHONE>00 45 2613 7490</MOBILE_PHONE><ADDRESS><DEPARTMENT>The Cochrane Anaesthesia Review Group, Rigshospitalet &amp; Department of Anaesthesiology</DEPARTMENT><ORGANISATION>University of Copenhagen Herlev Hospital</ORGANISATION><ADDRESS_1>Herlev Ringvej</ADDRESS_1><CITY>Herlev</CITY><ZIP>2730</ZIP><COUNTRY CODE="DK">Denmark</COUNTRY><PHONE_1>+45 44 88 44 88  879</PHONE_1><PHONE_2>+45 26 13 74 90</PHONE_2><FAX_1>+45 35 45 74 54</FAX_1></ADDRESS></PERSON><PERSON ID="8144" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Andrew</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Smith</LAST_NAME><POSITION>Consultant Anaesthetist and Associate Director (Research and Development) Director, Lancaster Patient Safety Research Unit</POSITION><EMAIL_1>andrew.f.smith@mbht.nhs.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Anaesthetics</DEPARTMENT><ORGANISATION>Royal Lancaster Infirmary</ORGANISATION><ADDRESS_1>Ashton Road</ADDRESS_1><CITY>Lancaster</CITY><ZIP>LA1 4RP</ZIP><REGION>Lancashire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1524 583517</PHONE_1><FAX_1>+ 44 1524 583519</FAX_1></ADDRESS></PERSON><PERSON ID="25653729764032995954110719121408" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Sharon</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Lewis</LAST_NAME><POSITION>Assistant Researcher</POSITION><EMAIL_1>Sharon.Lewis@mbht.nhs.uk</EMAIL_1><EMAIL_2>sharonrlewis@googlemail.com</EMAIL_2><ADDRESS><DEPARTMENT>Patient Safety Research</DEPARTMENT><ORGANISATION>Royal Lancaster Infirmary</ORGANISATION><ADDRESS_1>Pointer Court 1, Ashton Road</ADDRESS_1><CITY>Lancaster</CITY><ZIP>LA1 1RP</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1524 583517</PHONE_1><PHONE_2>+44 1524 516485</PHONE_2><FAX_1>+44 1524 583519</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-02-17 11:26:56 +0000" MODIFIED_BY="Jane Cracknell">
<UP_TO_DATE>
<DATE DAY="30" MONTH="6" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="6" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="3" MONTH="3" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-03-14 10:15:32 +0000" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-03-14 10:15:22 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="14" MONTH="3" YEAR="2014"/>
<DESCRIPTION>
<P>The existing search strategy was updated from May 2009 to June 2013. This yielded 261 new potential titles. We found no new included studies, but one additional study is awaiting assessment</P>
<P>The review was converted to new review format, and we used the Cochrane 'Risk of bias' tool to assess the quality of included studies. We added a 'Summary of findings' table</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-03-14 10:15:32 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="14" MONTH="3" YEAR="2014"/>
<DESCRIPTION>
<P>This review is an update of the previous Cochrane systematic review<BR/>(<LINK REF="REF-Pedersen-2009" TYPE="REFERENCE">Pedersen 2009</LINK>), which included five RCTs. Three new authors joined the review team for this update: Amanda Nicholson, Andrew Smith and Sharon Lewis. The contact person has been changed to Amanda Nicholson</P>
<P>Our review reached the same conclusions as were reached in the previous version</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-12-17 13:38:48 +0000" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-12-17 13:38:48 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="12" MONTH="10" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-10-12 13:56:27 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="7" MONTH="9" YEAR="2009"/>
<DESCRIPTION>
<P>New order of authors, previously: Pedersen T, Møller AM, Hovhannisyan K; now:Møller AM.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2009-09-07 09:49:51 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="15" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>A new author Karen Hovhannisyan has joined the review team.</P>
<P>He replaces Bente Dyrlund Pedersen who co-authored <LINK REF="REF-Pedersen-2003a" TYPE="REFERENCE">Pedersen 2003a</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-09-07 09:49:54 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="15" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>We re-ran the search strategy in all the databases up to May 2009. We searched three new databases (CINAHL, ISI Web of Science, and LILACS). We retrieved 133 studies. We identified and included one new randomized controlled trial in the review (<LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>). This new study has not changed the review's conclusion.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-01-12 12:20:30 +0000" MODIFIED_BY="Karen Hovhannisyan">
<DATE DAY="16" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-06-15 11:59:48 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="27" MONTH="7" YEAR="2005"/>
<DESCRIPTION>
<P>Second Update, Issue 4, 2005:<BR/>We found no new randomized controlled trials examining the impact of perioperative monitoring with pulse oximetry.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2009-06-15 11:59:37 +0100" MODIFIED_BY="Jane Cracknell">
<DATE DAY="31" MONTH="1" YEAR="2003"/>
<DESCRIPTION>
<P>First Update, Issue 2, 2003.<BR/>We found no new randomized controlled trials examining the impact of perioperative monitoring with pulse oximetry.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<SOURCE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<NAME>NIHR Cochrane Collaboration Programme Grant. Enhancing the safety, quality and productivity of perioperative care. Project Ref: 10/4001/04</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<UL>
<LI>This grant funds the work of AN, AS and SL on this review</LI>
</UL>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-03-14 10:16:09 +0000" MODIFIED_BY="Jane Cracknell">
<SUMMARY MODIFIED="2014-03-10 11:33:15 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2013-12-17 13:54:02 +0000" MODIFIED_BY="[Empty name]">Does monitoring oxygen level with a pulse oximeter during and after surgery improve patient outcomes?</TITLE>
<SUMMARY_BODY MODIFIED="2014-03-10 11:33:15 +0000" MODIFIED_BY="[Empty name]">
<P>Oxygen is carried around the body attached to haemoglobin in the blood. By passing light through the skin, pulse oximeters monitor how much oxygen the blood is carrying. Hypoxaemia&#8212;when the level of oxygen in the blood falls below optimal levels&#8212;is a risk during surgery when patient breathing and ventilation may be affected by anaesthesia or other drugs. Medical staff often monitor patients during and after surgery using pulse oximetry, but it is not clear whether this practise reduces the risk of adverse events after surgery. We reviewed the evidence on the effect of pulse oximeters on outcomes of surgical patients. In this update of the review, the search is current to June 2013. We identified five studies in which a total of 22,992 participants had been allocated at random to be monitored or not monitored with a pulse oximeter. These studies were not similar enough for their results to be combined statistically. Study results showed that although pulse oximetry can detect a deficiency of oxygen in the blood, its use does not affect a person's cognitive function and does not reduce the risk of complications or of dying after anaesthesia. These studies were large enough to show a reduction in complications, and care was taken to ensure that outcomes were assessed in the same way in both groups. The studies were conducted in developed countries, where standards of anaesthesia and nursing care are high. It is possible that pulse oximetry may have a greater impact on outcomes in other geographical areas with less comprehensive provision of health care.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<ABS_BACKGROUND MODIFIED="2014-03-10 11:22:15 +0000" MODIFIED_BY="[Empty name]">
<P>This is an update of a review last published in Issue 9, 2009, of <I>The Cochrane Library</I>. Pulse oximetry is used extensively in the perioperative period and might improve patient outcomes by enabling early diagnosis and, consequently, correction of perioperative events that might cause postoperative complications or even death. Only a few randomized clinical trials of pulse oximetry during anaesthesia and in the recovery room have been performed that describe perioperative hypoxaemic events, postoperative cardiopulmonary complications and cognitive dysfunction.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2014-03-10 11:22:15 +0000" MODIFIED_BY="[Empty name]">
<P>To study the use of perioperative monitoring with pulse oximetry to clearly identify adverse outcomes that might be prevented or improved by its use.</P>
<P>The following hypotheses were tested.</P>
<P>1. Use of pulse oximetry is associated with improvement in the detection and treatment of hypoxaemia.</P>
<P>2. Early detection and treatment of hypoxaemia reduce morbidity and mortality in the perioperative period.</P>
<P>3. Use of pulse oximetry per se reduces morbidity and mortality in the perioperative period.</P>
<P>4. Use of pulse oximetry reduces unplanned respiratory admissions to the intensive care unit (ICU), decreases the length of ICU readmission or both.</P>
<P>
<BR/>
</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 5), MEDLINE (1966 to June 2013), EMBASE (1980 to June 2013), CINAHL (1982 to June 2013), ISI Web of Science (1956 to June 2013), LILACS (1982 to June 2013) and databases of ongoing trials; we also checked the reference lists of trials and review articles. The original search was performed in January 2005, and a previous update was performed in May 2009.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-03-10 11:25:51 +0000" MODIFIED_BY="[Empty name]">
<P>We included all controlled trials that randomly assigned participants to pulse oximetry or no pulse oximetry during the perioperative period.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-03-10 11:26:10 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed data in relation to events detectable by pulse oximetry, any serious complications that occurred during anaesthesia or in the postoperative period and intraoperative or postoperative mortality.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-03-10 11:25:41 +0000" MODIFIED_BY="[Empty name]">
<P>The last update of the review identified five eligible studies. The updated search found one study that is awaiting assessment but no additional eligible studies. We considered studies with data from a total of 22,992 participants that were eligible for analysis. These studies gave insufficient detail on the methods used for randomization and allocation concealment. It was impossible for study personnel to be blinded to participant allocation in the study, as they needed to be able to respond to oximetry readings. Appropriate steps were taken to minimize detection bias for hypoxaemia and complication outcomes. Results indicated that hypoxaemia was reduced in the pulse oximetry group, both in the operating theatre and in the recovery room. During observation in the recovery room, the incidence of hypoxaemia in the pulse oximetry group was 1.5 to three times less. Postoperative cognitive function was independent of perioperative monitoring with pulse oximetry. A single study in general surgery showed that postoperative complications occurred in 10% of participants in the oximetry group and in 9.4% of those in the control group. No statistically significant differences in cardiovascular, respiratory, neurological or infectious complications were detected in the two groups. The duration of hospital stay was a median of five days in both groups, and equal numbers of in-hospital deaths were reported in the two groups. Continuous pulse oximetry has the potential to increase vigilance and decrease pulmonary complications after cardiothoracic surgery; however, routine continuous monitoring did not reduce transfer to an ICU and did not decrease overall mortality.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>These studies confirmed that pulse oximetry can detect hypoxaemia and related events. However, we found no evidence that pulse oximetry affects the outcome of anaesthesia for patients. The conflicting subjective and objective study results, despite an intense methodical collection of data from a relatively large general surgery population, indicate that the value of perioperative monitoring with pulse oximetry is questionable in relation to improved reliable outcomes, effectiveness and efficiency. Routine continuous pulse oximetry monitoring did not reduce transfer to the ICU and did not decrease mortality, and it is unclear whether any real benefit was derived from the application of this technology for patients recovering from cardiothoracic surgery in a general care area.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-03-14 10:16:09 +0000" MODIFIED_BY="Jane Cracknell">
<BACKGROUND MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>. </P>
<CONDITION MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Recent studies have suggested that hypoxaemia is common in the operating theatre and in the recovery room. Hypoxaemia is one of the most feared adverse events during anaesthesia and in the recovery period. For the individual patient, it is unpredictable at which level of hypoxaemia the brain, heart and other organs suffer adverse effects<I>
<B> </B>
</I>and to what extent irreversible damage may arise. Many factors, such as cardiac output, haemoglobin concentration and oxygen demand, affect the lowest tolerable value of oxyhaemoglobin saturation (<LINK REF="REF-Bendixen-1963" TYPE="REFERENCE">Bendixen 1963</LINK>). The occurrence and possible pathogenesis of perioperative hypoxaemia were described many years ago (<LINK REF="REF-Laver-1964" TYPE="REFERENCE">Laver 1964</LINK>; <LINK REF="REF-Nunn-1965" TYPE="REFERENCE">Nunn 1965</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-03-10 11:39:00 +0000" MODIFIED_BY="[Empty name]">
<P>The introduction of the pulse oximeter, a clinical monitor of oxygen saturation and pulsation levels, has made it possible to monitor perioperative hypoxaemia by using a non-invasive continuous measuring technique (<LINK REF="REF-Severinghaus-1992" TYPE="REFERENCE">Severinghaus 1992</LINK>). The greatest value of pulse oximetry lies in its ability to provide an early warning of hypoxaemia. Monitoring with pulse oximetry might improve patient outcomes by enabling early diagnosis and, consequently, correction of perioperative events that might cause postoperative complications or even death (<LINK REF="REF-Cooper-1984" TYPE="REFERENCE">Cooper 1984</LINK>). An operational definition of such an event is an undesirable incident that required intervention and did, or possibly could, cause complications or death. Such events may be attributed to pathophysiological processes, malfunction of the gas supply or equipment or human error, for example, oesophageal intubation or anaesthetic mismanagement. For many of these events, hypoxaemia is possibly the most common mechanism responsible for eventual adverse outcomes (<LINK REF="REF-Cooper-1987" TYPE="REFERENCE">Cooper 1987</LINK>).</P>
</INTERVENTION>
<IMPORTANCE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Many departments and societies of anaesthesiology have adopted standards for perioperative patient monitoring, including the use of pulse oximetry, to improve anaesthesia care in accordance with the hypothesis that this may reduce perioperative complications. Monitoring with pulse oximetry permits early diagnosis and treatment of hypoxaemia, thus reducing the incidence and severity of this condition (<LINK REF="REF-Canet-1991" TYPE="REFERENCE">Canet 1991</LINK>; <LINK REF="REF-Cote-1991" TYPE="REFERENCE">Cote 1991</LINK>). Only a few randomized clinical trials of pulse oximetry performed during anaesthesia and in the recovery room describe perioperative hypoxaemic events, postoperative cardiopulmonary complications, cognitive dysfunction or admission to the intensive care unit (ICU) (<LINK REF="REF-Cote-1988" TYPE="REFERENCE">Cote 1988</LINK>; <LINK REF="REF-Cote-1991" TYPE="REFERENCE">Cote 1991</LINK>; <LINK REF="REF-M_x00f8_ller-1994" TYPE="REFERENCE">Møller 1994</LINK>; <LINK REF="REF-Moller-1998" TYPE="REFERENCE">Moller 1998</LINK>; <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>). It is important to review available studies to assess whether monitoring with pulse oximetry confers long-term benefit for patients.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2014-03-10 11:42:08 +0000" MODIFIED_BY="[Empty name]">
<P>To study the use of perioperative monitoring with pulse oximetry to clearly identify adverse outcomes that might be prevented or improved by its use.</P>
<P>The following hypotheses were tested.</P>
<OL>
<LI>Use of pulse oximetry is associated with improvement in the detection and treatment of hypoxaemia.</LI>
<LI>Early detection and treatment of hypoxaemia reduce morbidity and mortality in the perioperative period.</LI>
<LI>Use of pulse oximetry per se reduces morbidity and mortality in the perioperative period.</LI>
<LI>Use of pulse oximetry reduces unplanned respiratory admissions to the ICU, decreases the length of ICU readmission or both.</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<SELECTION_CRITERIA MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<CRIT_STUDIES MODIFIED="2014-03-10 11:42:23 +0000" MODIFIED_BY="[Empty name]">
<P>We included all randomized and quasi-randomized controlled trials examining the use of pulse oximetry or no pulse oximetry during the perioperative period, including in the operating theatre and in the recovery room. We included trials irrespective of blinding, numbers of participants randomly assigned or the language of the article.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2014-03-10 11:42:30 +0000" MODIFIED_BY="[Empty name]">
<P>We included patients,18 years of age and older, who were undergoing surgery with anaesthesia.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>We included the following intervention:<I>
<B> </B>
</I>monitoring<I>
<B> </B>
</I>with pulse oximetry compared to no monitoring with pulse oximetry during the anaesthesia and recovery periods.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-03-10 11:44:05 +0000" MODIFIED_BY="[Empty name]">
<P>The primary outcome measures were postoperative complications and mortality from all causes, assessed at the end of the follow-up period scheduled for each trial.</P>
<OL>
<LI>Any serious complications that occurred during anaesthesia or in the postoperative period: admittance to postoperative intensive care due to respiratory insufficiency, circulatory insufficiency or infection; respiratory insufficiency due to pneumonia (fever, chest x-ray or positive culture), atelectasis (chest x-ray) or pneumothorax (diagnosed on chest x-ray), or requiring intervention; cardiovascular insufficiency (cardiac arrest, cardiac failure or myocardial infarction); renal and hepatic insufficiency; neurological and cognitive dysfunction (measuring memory function using the Weschler memory scale) or serious infection requiring antibiotics.</LI>
<LI>Intraoperative or postoperative mortality.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<OL>
<LI>Events detectable by pulse oximetry.</LI>
<OL>
<LI>Hypoxaemia (pulse oximetry estimate of arterial oxyhaemoglobin saturation (SpO<SUB>2</SUB>) &lt; 90%, corresponding to arterial oxygen tension &lt; 7.9 kPa).</LI>
</OL>
<LI>Causes of events.</LI>
<OL>
<LI>Patient respiratory causes of hypoxaemia (pneumothorax, bronchospasm, air embolus, respiratory depression, apnoea, airway obstruction, pneumonia, ventilatory failure and pulmonary emboli).</LI>
<LI>Patient mechanical causes of hypoxaemia (oesophageal or main stem intubation, mucus plug or kinked endotracheal tube).</LI>
<LI>Delivery system causes of hypoxaemia (anaesthesia machine and gas supply problems).</LI>
</OL>
<LI>Interventions that may prevent, attenuate or shorten these events include:</LI>
<OL>
<LI>airway support;</LI>
<LI>endotracheal intubation;</LI>
<LI>manual or mechanical ventilation;</LI>
<LI>oxygen treatment;</LI>
<LI>pressors and inotropes; and</LI>
<LI>fluid treatment.</LI>
</OL>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<ELECTRONIC_SEARCHES MODIFIED="2014-03-10 11:46:51 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 5), see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; MEDLINE via Ovid SP (1966 to June 2013), see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; EMBASE via Ovid SP (1980 to June 2013), see <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>; CINAHL via EBSCO host (1982 to June 2013), see <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>; ISI Web of Science (1956 to June 2013), see <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>; and LILACS via the BIREME interface (1982 to June 2013), see <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>. The original search was performed in January 2005 with an update in May 2009.</P>
<P>We searched the following databases of ongoing trials by using the free-text terms <I>oximetry, oxymetry </I>and<I> pulse oximetry</I>.</P>
<OL>
<LI>
<A HREF="http://www.controlled-trials.com/">Current Controlled Trials</A>, including the UK Clinical Trials Gateway and The Wellcome Trust.</LI>
<LI>
<A HREF="http://ClinicalTrials.gov">ClinicalTrials.gov</A>.</LI>
<LI>
<A HREF="http://www.koreamed.org/SearchBasic.php">KoreaMed</A>.</LI>
<LI>
<A HREF="http://indmed.nic.in/">Indian Medlars Center (IndMED)</A>.</LI>
<LI>
<A HREF="http://www.anzctr.org.au/trialSearch.aspx">Australian New Zealand Clinical Trials Registry</A>.</LI>
<LI>
<A HREF="http://www.who.int/trialsearch/">International Clinical Trials Registry Platform (ICTRP)</A>.</LI>
<LI>
<A HREF="http://register.germanctr.de/drks/start.faces">German Clinical Trials Register</A>.</LI>
<LI>
<A HREF="http://www.trialregister.nl/trialreg/admin/rctsearch.asp">The Netherlands National Trial Register</A>.</LI>
</OL>
<P>
<BR/>We imposed no language restrictions.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>We handsearched the bibliography of each article to look for relevant references.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<STUDY_SELECTION MODIFIED="2014-03-10 11:47:40 +0000" MODIFIED_BY="[Empty name]">
<P>We selected trials to be included in the systematic review based on the results of the search.<I> </I>For the updated search from 2009 to 2013, three review authors (KH, AN and AS) scanned the titles and abstracts of reports identified by electronic searching to produce a list of possibly relevant reports. Two review authors (AN and AS for this update; TP and AM for previous searches) independently assessed all studies for inclusion. We retrieved all eligible studies in full text.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-03-10 11:47:57 +0000" MODIFIED_BY="[Empty name]">
<P>We extracted the following data on randomization and blinding procedures.</P>
<OL>
<LI>Numbers of randomly assigned participants.</LI>
<LI>Numbers of participants not randomly assigned and the reasons for this.</LI>
<LI>Exclusion after randomization.</LI>
<LI>Dropouts.</LI>
<LI>Methods of hypoxaemia assessment in both intervention and control groups.</LI>
<LI>Methods of recording clinical interventions in both intervention and control groups.</LI>
<LI>Blinding of participants and observers.</LI>
</OL>
<P>We extracted data on perioperative complications and deaths.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The Cochrane 'Risk of bias' tool has been introduced since the last update (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). In this update, two review authors (AN and AS) reviewed all included studies using this tool in <LINK REF="REF-RevMan-5.2" TYPE="REFERENCE">RevMan 5.2</LINK> to assess the quality of study design and the extent of potential bias. We considered the following domains.</P>
<OL>
<LI>Sequence generation.</LI>
<LI>Allocation concealment.</LI>
<LI>Blinding of participants, personnel and outcomes assessors.</LI>
<LI>Incomplete outcome data.</LI>
<LI>Selective outcomes reporting.</LI>
</OL>
<P>We considered a study to be at low risk of bias from sequence generation if details of the randomization method were given, such as computer-generated numbers or centralized randomization by telephone. We considered a study to be at low risk of bias from allocation concealment if appropriate methods were described, such as numbered or coded identical containers administered sequentially; an on-site computer system that could be accessed only after the characteristics of an enrolled participant had been entered; or sequentially numbered, sealed, opaque envelopes.</P>
<P>For this review topic, it is impossible for the personnel involved to be blinded to the allocation of the participant, as the intervention involves monitoring oxygen levels and then taking appropriate follow-up action. Different patterns of care based on results of pulse oximetry are the aim of the intervention; therefore a high risk of performance bias will be inevitable. The risk of detection bias will depend on the outcome considered. Detection bias of hypoxaemia will be minimized if all participants are monitored but results are screened/ hidden from the clinical staff<I>
<B> </B>
</I>in the control group. Detection bias for complications and transfer to the ICU can be minimized if personnel not involved in the care of participants assess these outcomes. Mortality will be at low risk of detection bias.</P>
<SUBSECTION>
<HEADING LEVEL="3">Statistics</HEADING>
<P>We used Review Manager version 5.2<I>
<B> </B>
</I>(<LINK REF="REF-RevMan-5.2" TYPE="REFERENCE">RevMan 5.2</LINK>) in this update. The decision whether to meta-analyse data was based on an assessment of whether study population, intervention, comparison and outcomes were sufficiently similar to ensure a clinically meaningful result.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Summary of findings</HEADING>
<P>In this update, we used the principles of the GRADE system to perform an overall assessment of evidence related to each of the following outcomes<I>
<B> </B>
</I>(<LINK REF="REF-Guyatt-2008" TYPE="REFERENCE">Guyatt 2008</LINK>).</P>
<OL>
<LI>Complications.<I> </I>
</LI>
<LI>Mortality.<I> </I>
</LI>
<LI>Hypoxaemia.<I> </I>
</LI>
<LI>Related interventions.</LI>
</OL>
<P>The GRADE approach incorporates risk of bias, directness of evidence, heterogeneity of data, precision of effect estimates and risk of publication bias to provide an overall measure of how confident we can be that our estimate of effect is correct. AN used GRADEPRO software to create a 'Summary of findings' table for each outcome and AS and TP reviewed and checked the table.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-03-14 10:16:09 +0000" MODIFIED_BY="Jane Cracknell">
<STUDY_DESCRIPTION MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<SEARCH_RESULTS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The existing review had five included studies with a total of 22,992 participants. In this new update, we found 261 new papers in our searches of electronic databases. One study was potentially eligible (<LINK REF="STD-Haines-2012" TYPE="STUDY">Haines 2012</LINK>); we reviewed this in full text but have been unable to contact the study authors to clarify eligibility<I>
<B> </B>
</I>(<LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>). We found no new studies in our updated search of clinical trial databases or review of reference lists. Overall search results for this review (including all updates) are summarized in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Five studies are included in the review (<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>; <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>; <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>; <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>; <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>) with a total of 22,992 participants. These studies are summarized in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<SUBSECTION>
<HEADING LEVEL="5">Study populations</HEADING>
<P>Two studies focused on participants undergoing cardiac surgery and studied the effect of pulse oximetry monitoring in the cardiac ICU<I>
<B> </B>
</I>(<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>) or in the cardiac recovery ward<I>
<B> </B>
</I>(<LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>) rather than during surgery. Participants in the other three included studies were undergoing general surgery and were monitored from the time arrival to the operating room (OR) until discharge from the recovery room postanaesthesia care unit (PACU).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Intervention and comparison</HEADING>
<P>Intervention groups in all included studies were monitored with<I>
<B> </B>
</I>continuous displayed pulse oximetry, with alarms sounding in two studies (<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>; <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>), and were monitored at a telemetry station in <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>. Methods of oxygen saturation monitoring in control groups varied and were poorly described. In two studies, the control group also received continuous pulse oximetry, but the results were not available to staff<I>
<B> </B>
</I>(<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>; <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>), except in cases of prolonged desaturation in one study (<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>). Intermittent blood gas readings (at least every six hours) were specified in<I>
<B> </B>
</I>
<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>, and in <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK> the control group received intermittent oximetry monitoring as required.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Outcomes</HEADING>
<P>Four studies reported hypoxaemia outcomes in intervention and control groups (<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>; <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>; <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>; <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>).<I>
<B> </B>
</I>In two studies (<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>; <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>), these outcomes were based on continuous pulse oximetry monitoring in both groups, but in <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK> and <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>, the method of detection of hypoxaemia differed between intervention and control groups. Three studies reported interventions or variations in care aimed at preventing or attenuating hypoxaemia and resulting complications (<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>; <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>; <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>). All three studies reported numbers of changes in ventilatory support and doses of oxygen given. <LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK> and <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> also reported the numbers of blood gas analyses performed, and <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> reported on the use of pharmacological agents to reverse neuromuscular blockade or the effects of opioids.</P>
<P>
<LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> reported the incidence of a range of complications on the seventh postoperative day (POD7) or at discharge, including respiratory, cardiovascular and neurological disorders and infections. <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK> reported on the cognitive function of participants before and after surgery (POD7 and in a subsample at three months). <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK> studied the unplanned transfer of participants from the standard recovery ward to intensive care and in-hospital mortality.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-03-10 12:00:08 +0000" MODIFIED_BY="[Empty name]">
<P>We excluded two studies because of ineligible design (<LINK REF="STD-Cullen-1992" TYPE="STUDY">Cullen 1992</LINK>; <LINK REF="STD-Mateer-1993" TYPE="STUDY">Mateer 1993</LINK>). See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> for additional details.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Risk of bias assessments for included studies are summarized in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<ALLOCATION MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>All of the included studies gave insufficient details concerning random sequence generation and allocation concealment, and we rated all studies to be at<I>
<B> </B>
</I>unclear risk of selection bias. Two studies used a cluster-randomized design with operating theatres randomly assigned to using or not using pulse oximetry after participants undergoing elective surgery had been allocated to lists, with emergency cases assigned by drawing envelopes from a stack (<LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>; <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>)<I>.<B> </B>
</I>Three studies mentioned the use of sealed envelopes but did not give full details of whether the envelopes were opaque and sequentially numbered (<LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>; <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>; <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>In all included studies, study personnel were not blinded to participant allocation and were able to modify the care received according to pulse oximetry results. We therefore concluded that all studies were at high risk of performance bias for all outcomes.</P>
<P>In two studies<I>
<B> </B>
</I>(<LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>; <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>),<I>
<B> </B>
</I>hypoxaemia was assessed by pulse oximetry in both control and intervention groups, and the data were recorded automatically. We rated these studies at low risk of detection bias for hypoxaemia. In<I>
<B> </B>
</I>
<LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK> and <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>,<I>
<B> </B>
</I>the method of detection of hypoxaemia in the control group was not fully described and relied on clinical observation and arterial blood gas analysis. We considered the hypoxaemia outcome to be at high risk of detection bias in these studies.</P>
<P>In <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK> and <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>, OR personnel, who were aware of participants' allocation, recorded changes to participant care. However, staff who assessed postoperative complications or cognitive function were unaware of participant allocation. We considered that these studies were at high risk of detection bias for changes to participant care but at low risk of detection bias for complications. In <LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>, it was unclear how changes to participant care were recorded. In<I>
<B> </B>
</I>
<LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>, staff on the ward made the decision to transfer a participant to ICU with no standardized criteria reported. We considered this outcome to be at high risk of detection bias, but in-hospital mortality to be at low risk.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Dropout rates varied between 5% and 10% in all included studies, with a maximum of 14.6% in <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK> due to the more complicated cognitive function test. We considered most studies to be at low risk of attrition bias because the attrition rate was similar in both groups. <LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>, however, reported more withdrawals from the control group due to technical problems.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-11-25 15:45:18 +0000" MODIFIED_BY="Jane Cracknell">
<P>We found no evidence of selective reporting bias. </P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Most studies were supported in some way by the manufacturers of the monitoring equipment. In most studies, this took the form of the loan of the equipment. Nellcor supported <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK> with an unsupported grant. The role and precise involvement of the manufacturers were unclear.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-03-14 10:16:09 +0000" MODIFIED_BY="Jane Cracknell">
<P>Searching yielded five reports. All outcome measures in the included studies were extracted and are detailed in the table <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. The types of outcome measures were separated into perioperative complications and events detectable by pulse oximetry that could result in complications. This is considered in the same way below.</P>
<P>Studies used various ways to assess postoperative outcomes.</P>
<OL>
<LI>Events with hypoxaemia measured with blood gas analysers or pulse oximetry (two trials).</LI>
<LI>Tests of cognitive function: Wechsler memory scale, continuous reaction time and subjective perception of cognitive dysfunction (test of memory) (one trial).</LI>
<LI>Clinical outcomes: respiratory, cardiovascular and neurological complications following anaesthesia (one trial).</LI>
<LI>Unplanned respiratory admissions to the ICU, decreased length of ICU readmission or both (one trial).</LI>
</OL>
<P>Due to the variety of study population, comparison group and outcome variables in the five studies, there are no two groups which could be combined by formal meta-analysis.</P>
<SUBSECTION>
<HEADING LEVEL="3">Incidence of hypoxaemia</HEADING>
<P>Both studies assessed as having low risk of detection bias for hypoxaemia found an increased incidence of hypoxaemia in the control group. In the study of <LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>, clinically unapparent desaturations were detected in seven of 15 participants in the control group without pulse oximetry compared with none in the pulse oximetry group. <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK> found that hypoxaemia was reduced in the pulse oximetry group, both in the operating theatre and in the recovery room. During observation in the recovery room, the incidence of hypoxaemia in the pulse oximetry group was 1.5 to three times less, and no participant experienced extreme or severe hypoxaemia. In the pulse oximetry group, the lowest recorded SpO<SUB>2</SUB> value in the recovery room (mean 89.4%) was greater than the value in the group without pulse oximetry (mean 87.2%).</P>
<P>Both of the studies at high risk of detection bias for hypoxaemia reported an increased incidence of hypoxaemia in the intervention group. In <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>, hypoxaemia was detected in 818/10,312 (7.9%) in the oximetry group compared with 41/10,490 (0.4%) in the control group. In this study, a higher rate of hypoventilation and endobronchial intubation was reported in the oximetry group, consistent with better identification of ventilation problems in the oximetry group. In <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>, 7.8% of participants in the oximetry group were diagnosed with hypoxaemia in the OR and 11.7% in the recovery room compared with 0.3% in the OR and 0.5% in the OR for participants in the control group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Changes in patient care</HEADING>
<P>In <LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>, the number of changes in ventilatory support per postoperative intensive care unit (ICU) stay was not different between groups, whereas the dose of supplemental oxygen was adjusted more frequently (usually lowered) in the group without pulse oximetry. No evidence was found of a significant difference between groups regarding the duration of postoperative mechanical ventilation or ICU stay. In <LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>, participants in the oximetry group were more likely to receive supplemental oxygen (45% compared with 35% receiving more than 3 L/min of oxygen in the recovery room). <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> also reported increased use of supplemental oxygen in the PACU in the oximetry group (6.5% receiving more than 3 L/min compared with 2.8% in the control group). The proportion of participants discharged from the recovery room with an order for supplemental oxygen was 13.3% in the oximeter group and 3.5% in the control group.</P>
<P>In <LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>, the number of blood gas analyses was greater in the control group than in the oximetry group (mean 23.2 (standard deviation (SD) 8.8) vs 12.4 (7.5); P &lt; 0.001). By contrast, <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> found no difference between groups. This is likely to reflect the protocol in <LINK REF="STD-Bierman-1992" TYPE="STUDY">Bierman 1992</LINK>, which specified blood gas analyses at least every six hours in the control group.</P>
<P>In <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>, more participants in the oximetry group received naloxone, and these individuals had a longer stay in the PACU. The higher proportion of participants treated with naloxone in the oximetry group may be an example of how the oximeter readings pointed to a problem to which the staff reacted.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Cognitive dysfunction</HEADING>
<P>
<LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK> demonstrated that postoperative cognitive function, as measured by the Wechsler memory scale and by continuous reaction time, was independent of perioperative monitoring with pulse oximetry. Postoperative subjective reports (by questionnaire) of cognitive deficits revealed no statistically significant difference: 7% in the pulse oximetry group and 11% in the group without pulse oximetry believed their cognitive abilities had decreased. No statistically significant difference was noted in the ability to concentrate (10% vs 9%). This study reported no evidence of lessened postoperative cognitive impairment after perioperative monitoring with pulse oximetry.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Clinical measures of complications to the time of discharge</HEADING>
<P>The study of <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>, including 20,802 surgical participants randomly assigned to monitoring with pulse oximetryor no monitoring, found that one or more postoperative complications occurred in 10% of participants in the oximetry group and in 9.4% in the control group. The two groups did not differ in the number of cardiovascular, respiratory, neurological, or infectious complications. The duration of hospital stay was a median of five days in both groups. An equal number of in-hospital deaths occurred in the two groups: 1.1% in the oximeter group and 1.0% in the control group; a total of seven deaths were classified as possibly anaesthesia related: three deaths in the oximetry group and four in the control group. The seven deaths did not display any specific pattern. A questionnaire completed by the anaesthesiologists revealed that 18% of them had experienced a situation in which a pulse oximeter had helped to avoid a serious event or complication, and that 80% felt more secure when they used a pulse oximeter. Although monitoring with pulse oximetry prompted several changes in participant care, no evidence showed a reduction in the overall rate of postoperative complications when perioperative pulse oximetry was used.</P>
<P>The study of <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK> also reported no difference in in-hospital mortality between intervention and control groups, with 14 deaths among 589 participants (2.4%) in the intervention group and 14 among 630 (2.2%) in the control group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intensive care unit admissions from postsurgical care</HEADING>
<P>The study of <LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK> included 1219 participants enrolled from approximately 8300 patients who met the eligibility criteria. Rates of readmission to the ICU were similar in monitored and unmonitored groups. Of the 93 participants (8% of all participants) who were transferred to the ICU after enrolment, 40 were in the monitored group of 589 participants (6.7%) and 53 were in the unmonitored group of 630 participants (8.5%) (P <I>=<B> </B>
</I>0.33). Participants transferred to the ICU did not differ from those not transferred to the ICU (&#8220;discharged&#8221;) in terms of age, gender, race or surgical service. Starting in the cardiothoracic intensive care unit (CTICU) before transfer to the study floor was significantly associated with return to an ICU (odds ratio (OR) 2.1; 95% confidence interval (CI) 1.3 to 4.9; P<I>
<B> </B>=<B> </B>
</I>0.001). Reasons for transfer back to the ICU (determined by blinded review of ICU transfer notes) differed between monitored and unmonitored groups, with more pulmonary events reported in the unmonitored group compared with the continuous pulse oximetry (CPOX) monitored group (27/630 vs 8<I>
<B>/</B>
</I>589; P<I>
<B> </B>
</I>= 0.002). The use of CPOX did not impact<I>
<B> </B>
</I>on duration of stay in the hospital or total estimated cost of hospitalization when the entire cohort was examined. Routine CPOX and usual care groups had similar numbers of days from enrolment to discharge from the study, numbers of days from enrolment to discharge from the hospital, estimated costs while on the study floor and estimated costs for the entire hospital stay. The effects of death on study outcomes were assessed by reexamining study outcomes in a sensitivity analysis without including data from these participants. Deaths did not affect outcomes and did not produce or enhance differences between groups.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<SUBSECTION>
<HEADING LEVEL="2">Methodological quality</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Statistical analysis of data</HEADING>
</SUBSECTION>
<SUMMARY_OF_RESULTS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The latest updated search added no new studies, but the included studies confirmed that pulse oximetry improves the detection of hypoxaemia and related events such as hypoventilation. Alterations to participant care were more frequent in monitored participants. However, no evidence suggests that continuous monitoring with pulse oximetry reduced the incidence of postoperative complications or mortality (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Perioperative hypoxaemia and postoperative complications</HEADING>
<P>Comparisons of overall rates of perioperative hypoxaemia and postoperative complications are difficult with the present randomized studies because of the limited numbers of studies and participants, and because of differences in the types of outcomes investigated. It appears that general rates of hypoxaemia and complications in the present studies are at the same level as those reported in other studies (<LINK REF="REF-Mlinaric-1997" TYPE="REFERENCE">Mlinaric 1997</LINK>; <LINK REF="REF-Moller-1998" TYPE="REFERENCE">Moller 1998</LINK>; <LINK REF="REF-Pedersen-1994" TYPE="REFERENCE">Pedersen 1994</LINK>; <LINK REF="REF-Rheineck-1996" TYPE="REFERENCE">Rheineck 1996</LINK>; <LINK REF="REF-Stausholm-1997" TYPE="REFERENCE">Stausholm 1997</LINK>).</P>
<P>The demonstration of reduced extent of hypoxaemia and the ability to detect and correct potentially harmful events and to make several changes in patient care with pulse oximetry monitoring contrast with the fact that no reduction in the number of postoperative complications was found (<LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>). The fact that patients<I>
<B> </B>
</I>monitored with pulse oximetry have no change in outcome, despite the fact that they tend to be given more oxygen and naloxone (<LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>), is worth emphasizing. It indicates that merely increasing saturation levels from marginal to satisfactory probably is not going to make a difference in patient outcomes. In other words, the use of pulse oximetry as an early warning of moderate hypoxaemia does not appear to be beneficial even if the appropriate responses are instituted earlier than they would have been without pulse oximetry. This result conflicts with most anaesthesiologists' beliefs. In the closed claims analyses of adverse respiratory events in anaesthesia, the authors<I>
<B> </B>
</I>judged that better monitoring would have prevented adverse outcomes in 72% of the claims (<LINK REF="REF-Caplan-1990" TYPE="REFERENCE">Caplan 1990</LINK>; <LINK REF="REF-Tinker-1989" TYPE="REFERENCE">Tinker 1989</LINK>). In the general analysis of the role of monitoring devices in the prevention of anaesthetic mishaps, nearly 60% of the instances of death and brain damage were considered preventable by application of additional monitors. These studies have several limitations, including absence of a control group, a probable bias toward adverse outcomes and reliance on data provided by participants rather than by objective observers.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Postoperative cognitive dysfunction</HEADING>
<P>The relationship between perioperative hypoxaemia and impaired postoperative cognitive function is debated (<LINK REF="REF-Krasheninnikoff-1993" TYPE="REFERENCE">Krasheninnikoff 1993</LINK>). <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK> found that 9% of surgical participants thought that their mental function had deteriorated. In a more recent study (<LINK REF="REF-Moller-1998" TYPE="REFERENCE">Moller 1998</LINK>), postoperative cognitive dysfunction in the elderly, as identified by neuropsychological tests, was present in 25.8% of participants one week after surgery, and in 9.9% three months after surgery. However, hypoxaemia was not a significant risk factor for cognitive dysfunction at any time. Perioperative monitoring with pulse oximetry did not appear to affect participants' postoperative cognitive function. Tests of cognitive function are valuable in the study of anaesthetic drug effects, but many participants had unexplained complaints of impaired cognitive function that were not verified by objective tests (<LINK REF="REF-Moller-1998" TYPE="REFERENCE">Moller 1998</LINK>). One may speculate that application of a broader range of neuropsychological assessments than were used in the <LINK REF="REF-Moller-1998" TYPE="REFERENCE">Moller 1998</LINK> study could have detected varying deficits of an enduring nature. Using a broad range of tests, investigators have described moderate to severe cognitive dysfunction that lasted for several months after coronary bypass surgery (<LINK REF="REF-Townes-1989" TYPE="REFERENCE">Townes 1989</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pulse oximetry monitoring on intensive care unit admissions from postsurgical care</HEADING>
<P>The randomized clinical trial of third-generation CPOX technology (<LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>) reported that routine CPOX monitoring was not associated with an overall decreased transfer to ICU or with mortality. In this population of patients<I>
<B> </B>
</I>after cardiothoracic surgery, the use of CPOX was associated with reduced postoperative ICU admissions for pulmonary complications. It is possible that CPOX monitoring increases overall nursing vigilance, resulting in increased non-respiratory ICU transfers. If appropriate, such transfers may contribute to the benefits of CPOX observed in this study. If such transfers represent inappropriately aggressive care, then there is the potential for routine CPOX monitoring to further reduce ICU readmissions with further training of nurses. If a real benefit of CPOX is seen in reduced ICU transfer, then lack of reduction in the absolute rate of return to an ICU by CPOX use can also be considered a dilutional effect. The large group of participants who did well regardless of the monitoring overwhelms any beneficial effect of monitoring in the much smaller group, which may have benefited from the monitoring. This is similar to perioperative data, which show a decreased rate of hypoxaemia when pulse oximetry is used (<LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>) but no change in rare outcomes (myocardial infarction, stroke and death) (<LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Anaesthetists' perception of risk</HEADING>
<P>The study of <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> showed that 18% of participating anaesthesiologists reported one or more situations in which they thought pulse oximetry helped to avoid a serious event or complication. This subjective reporting suggests an effect of pulse oximetry monitoring on outcome, but objective figures for the rate of postoperative complications do not confirm this. A large contrast was also evident between the objective results of the study of <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> and the subjective opinions of participating anaesthesiologists regarding the usefulness of pulse oximetry.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The included studies come from countries (USA and Denmark) where standards of anaesthesia and nursing care are high. Almost all of the data were collected by a single group of investigators in Denmark (<LINK REF="STD-Moller-1992a" TYPE="STUDY">Moller 1992a</LINK>; <LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>; <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>). This reduces the generalizability of the results in terms of what might be found in other geographical areas where standards of care and assessment methods may be lower and pulse oximetry may have a greater impact on outcomes. Because the detected hypoxic events were treated, we do not really know what the differences in outcomes would have been if hypoxic events were neither detected nor treated. The studies were relatively well controlled and did not reproduce situations with a high likelihood of disaster.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The quality of randomization and allocation concealment in the included studies was often unclear from the study report, but there was nothing to suggest processes that introduced bias. Blinding of personnel to the allocation was impossible for this topic, and so all outcomes were at high risk of performance bias. The intervention being tested in practise is oximetry monitoring and resulting changes to care. Two studies paid careful attention to reducing detection bias for complications (<LINK REF="STD-Moller-1993b" TYPE="STUDY">Moller 1993b</LINK>; <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>), but other studies had the potential for increased detection of outcomes in the intervention group (<LINK REF="STD-Ochroch-2006" TYPE="STUDY">Ochroch 2006</LINK>). Although power analyses were not reported, <LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK> had a sufficient sample size to detect a change in complication rates from 9.5% to 8% with 80% power at 5% significance. It is therefore unlikely that a substantial reduction in complications was missed by this study.</P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<IMPLICATIONS_PRACTICE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The proliferation of monitors in anaesthesia is obvious. The goal of monitoring as an adjunct to clinical decision making is to directly reduce the incidence of complications. This is based on the premise that unambiguous and accurate information, which is readily interpretable and available, will help the anaesthesiologist in choosing and initiating correct therapeutic interventions. The unanswered question is whether the individual anaesthesiologist's performance&#8212;the human factor&#8212;is perhaps far more important than implementing new monitoring equipment or other new safety initiatives in a situation in which we wish to reduce the rate of postoperative complications. However, we do not know whether pulse oximetry might protect against the human factor when that factor is negligent.</P>
<P>Pulse oximetry monitoring substantially reduced the extent of perioperative hypoxaemia, enabled the detection and treatment of hypoxaemia and related respiratory events and promoted several changes in patient care. The implementation of perioperative pulse oximetry monitoring was not, however, the breakthrough that could reduce the number of postoperative complications. The question remains whether pulse oximetry improves outcomes in other situations. Pulse oximetry has already been adopted into clinical practice all over the world. It may be a tool that guides anaesthesiologists in the daily management of patients, in teaching situations, in emergencies and especially in caring for children. Although results of studies are not conclusive, the data suggest that there may be a benefit for a population at high risk of postoperative pulmonary complications. Results of the studies of general surgery indicate that perioperative monitoring with pulse oximetry does not improve clinically relevant outcomes, effectiveness or efficiency of care despite an intense, methodical collection of data from a large population.<BR/>
</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The science of human factors includes the psychological and mental factors that affect performance in the workplace. Monitoring systems should fit naturally with the way the anaesthesiologist works, thinks and interacts with the patient, the equipment and the operating room environment, so monitoring systems can, together with vigilance and clinical decision making, bring significant benefit.</P>
<P>Existing evidence demonstrates that pulse oximetry reduces the incidence of hypoxaemia but does not improve overall patient outcomes and does not reduce morbidity and mortality. We found no RCTs on pulse oximetry published after 2006. The use of oximeters is now so widespread that many anaesthesiologists in the developed world will not consider working without one. It is therefore uncertain whether any new large RCTs are likely to be performed (<LINK REF="REF-Shah-2013" TYPE="REFERENCE">Shah 2013</LINK>). All existing studies were conducted in affluent Western hospitals with good standards of patient care. The benefit of pulse oximetry monitoring has not been evaluated in more challenging healthcare settings, but there may be ethical queries about such studies.</P>
<P>The potential for continuous pulse oximetry to allow early intervention, or perhaps prevention of pulmonary complications, needs to be explored. Future studies might usefully include an evaluation of clinicians&#8217; responses to oximetry readings, perhaps shaped by clinical pathways or protocolized interventions. As the present studies illustrate, the problems are multitudinous. The worst problem is clearly the huge numbers of participants needed. By limiting the inclusion criteria to a specific subgroup of participants (e.g. participants older than 65 years, with cardiac risk factors, with American Society of Anesthesiologists (ASA) physical status III and IV or undergoing acute abdominal surgery), isolating more rigorous outcome variables and establishing wide co-operation between departments and countries, new monitoring and anaesthesia safety studies could be launched in the future.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>We thank Mathew Zacharias and Rodrigo Cavallazzi for editing the current updated version of this review.</P>
<P>We would like to acknowledge Nete Villebro, Janet Wale and Kathie Godfrey for their contributions to the plain language summary in the previous review (<LINK REF="REF-Pedersen-2005" TYPE="REFERENCE">Pedersen 2005</LINK>). We also would like to acknowledge Dr Bente Dyrlund Pedersen's contributions to our previous review (<LINK REF="REF-Pedersen-2003a" TYPE="REFERENCE">Pedersen 2003a</LINK>).<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Tom Pedesen is a co-author of one study included in the review (<LINK REF="STD-Moller-1993c" TYPE="STUDY">Moller 1993c</LINK>).</P>
<P>Amanda Nicholson: From March to August 2011, AN worked for the Cardiff Research Consortium, which provided research and consultancy services to the pharmaceutical industry. The Cardiff Research Consortium has no connection with AN's work with The Cochrane Collaboration. AN's husband has small direct holdings in several drug and biotech companies as part of a wider balanced share portfolio. See <LINK TAG="SOURCES_OF_SUPPORT" TYPE="SECTION">Sources of support</LINK>.</P>
<P>Karen Hovhannisyan: none known.</P>
<P>Ann Merete Møller: none known.</P>
<P>Andrew F Smith: none known.</P>
<P>Sharon R Lewis: none known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-03-10 12:48:52 +0000" MODIFIED_BY="[Empty name]">
<P>Tom Pedersen (TP), Amanda Nicholson (AN), Karen Hovhannisyan (KH), Ann Merete Møller (AM), Andrew F Smith (AS), Sharon R Lewis (SL)</P>
<P>Conceiving the review: TP, AM</P>
<P>Co-ordinating the review: TP, AM</P>
<P>Undertaking electronic and manual searches: TP, AM, KH</P>
<P>Screening search results: TP, AM, KH, AN</P>
<P>Organizing retrieval of papers: KH</P>
<P>Screening retrieved papers against inclusion criteria: TP, AM, KH, AN,AS</P>
<P>Appraising quality of papers: TP, AM, AN, AS</P>
<P>Extracting data from papers: TP, AM, AN</P>
<P>Writing to authors of papers for additional information: TP</P>
<P>Obtaining and screening data on unpublished studies: TP</P>
<P>Data management for the review: TP, AM</P>
<P>Entering data into Review Manager (<LINK REF="REF-RevMan-5.2" TYPE="REFERENCE">RevMan 5.2</LINK>): TP, KH</P>
<P>RevMan statistical data: TP, AM</P>
<P>Other statistical analysis not using RevMan: TP, AM</P>
<P>Double entry of data: TP, AM</P>
<P>Interpretation of data: TP, AM</P>
<P>Statistical inferences: TP, AM</P>
<P>Writing the review: TP, AM, KH, AN, SL</P>
<P>Securing funding for the review: TP</P>
<P>Guarantor for the review (one author): TP</P>
<P>Person responsible for reading and checking review before submission: TP</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>The Cochrane 'Risk of bias' tool was used in this update to assess the quality of included studies, and a 'Summary of findings' table was included.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<STUDIES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<INCLUDED_STUDIES MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bierman-1992" MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Jane Cracknell" NAME="Bierman 1992" YEAR="1992">
<REFERENCE MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bierman MI, Stein KL, Snyder JV</AU>
<TI>Pulse oximetry in the postoperative care of cardiac surgical patients</TI>
<SO>Chest</SO>
<YR>1992</YR>
<VL>102</VL>
<PG>1367-70</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:37:02 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:37:02 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE=" 1424853"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moller-1992a" MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Jane Cracknell" NAME="Moller 1992a" YEAR="1992">
<REFERENCE MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moller JT, Jensen PF, Johannessen NW, Espersen K</AU>
<TI>Hypoxaemia is reduced by pulse oximetry monitoring in the operating theatre and in the recovery room</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1992</YR>
<VL>68</VL>
<NO>2</NO>
<PG>146-50</PG>
<IDENTIFIERS MODIFIED="2009-04-27 22:08:42 +0100" MODIFIED_BY="Karen Hovhannisyan">
<IDENTIFIER MODIFIED="2009-04-27 22:08:42 +0100" MODIFIED_BY="Karen Hovhannisyan" TYPE="PUBMED" VALUE="1540455"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moller-1993b" MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Karen Hovhannisyan" NAME="Moller 1993b" YEAR="1993">
<REFERENCE MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Karen Hovhannisyan" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moller JT, Svennild I, Johannessen NW</AU>
<TI>Perioperative monitoring with pulse oximetry and late postoperative cognitive dysfunction</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1993</YR>
<VL>71</VL>
<NO>3</NO>
<PG>340-7</PG>
<IDENTIFIERS MODIFIED="2009-04-27 22:07:13 +0100" MODIFIED_BY="Karen Hovhannisyan">
<IDENTIFIER MODIFIED="2009-04-27 22:07:13 +0100" MODIFIED_BY="Karen Hovhannisyan" TYPE="PUBMED" VALUE="8398512"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moller-1993c" MODIFIED="2013-12-03 12:25:26 +0000" MODIFIED_BY="Jane Cracknell" NAME="Moller 1993c" YEAR="1993">
<REFERENCE MODIFIED="2013-12-03 12:25:26 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Moller JT, Johannessen NW, Espersen K, Ravlo O, Pedersen BD, Jensen PF, et al</AU>
<TI>Randomized evaluation of pulse oximetry in 20,802 patients: II. Perioperative events and postoperative complications</TI>
<SO>Anesthesiology</SO>
<YR>1993</YR>
<VL>78</VL>
<NO>3</NO>
<PG>445-53</PG>
<IDENTIFIERS MODIFIED="2009-06-10 14:04:48 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-10 14:04:48 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="8457045"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-11-21 14:50:09 +0000" MODIFIED_BY="Amanda Nicholson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moller JT, Pedersen T, Rasmussen LS, Jensen PF, Pedersen BD, Ravlo O, et al</AU>
<TI>Randomized evaluation of pulse oximetry in 20,802 patients: I. Design, demography, pulse oximetry failure rate, and overall complication rate</TI>
<SO>Anesthesiology</SO>
<YR>1993</YR>
<VL>78</VL>
<NO>3</NO>
<PG>436-44</PG>
<IDENTIFIERS MODIFIED="2013-11-21 14:50:07 +0000" MODIFIED_BY="Amanda Nicholson">
<IDENTIFIER TYPE="PUBMED" VALUE="8457044"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ochroch-2006" MODIFIED="2009-07-02 12:27:30 +0100" MODIFIED_BY="[Empty name]" NAME="Ochroch 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-07-02 12:27:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ochroch EA, Russell MW, Hanson WC 3rd, Devine GA, Cucchiara AJ, Weiner MG, et al</AU>
<TI>The impact of continuous pulse oximetry monitoring on intensive care unit admissions from a postsurgical care floor</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2006</YR>
<VL>102</VL>
<NO>3</NO>
<PG>868-75</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="16492843"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<STUDY DATA_SOURCE="PUB" ID="STD-Cullen-1992" MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Jane Cracknell" NAME="Cullen 1992" YEAR="1992">
<REFERENCE MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cullen DJ, Nemeskal AR, Cooper JB, Zaslavsky A, Dwyer MJ</AU>
<TI>Effect of pulse oximetry, age, and ASA physical status on the frequency of patients admitted unexpectedly to a postoperative intensive care unit and the severity of their anesthesia-related complications</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1992</YR>
<VL>74</VL>
<PG>177-80</PG>
<IDENTIFIERS MODIFIED="2009-04-27 22:12:36 +0100" MODIFIED_BY="Karen Hovhannisyan">
<IDENTIFIER MODIFIED="2009-04-27 22:12:36 +0100" MODIFIED_BY="Karen Hovhannisyan" TYPE="PUBMED" VALUE="1731535"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mateer-1993" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Mateer 1993" YEAR="1993">
<REFERENCE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mateer JR, Olson DW, Stueven HA, Aufderheide TP</AU>
<TI>Continuous pulse oximetry during emergency endotracheal intubation</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>1993</YR>
<VL>22</VL>
<PG>675-9</PG>
<IDENTIFIERS MODIFIED="2009-04-27 22:14:42 +0100" MODIFIED_BY="Karen Hovhannisyan">
<IDENTIFIER MODIFIED="2009-04-27 22:14:42 +0100" MODIFIED_BY="Karen Hovhannisyan" TYPE="PUBMED" VALUE="8457094"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Karen Hovhannisyan">
<STUDY DATA_SOURCE="PUB" ID="STD-Haines-2012" MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Amanda Nicholson" NAME="Haines 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Amanda Nicholson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haines KL, Downs JB, Mullen MB, Klonsky JA, Gallagher SF</AU>
<TI>Scheduled, Intermittent oximetry fails to detect postoperative hypoxemia after bariatric surgery</TI>
<SO>Journal of Surgical Research</SO>
<YR>2012</YR>
<VL>172</VL>
<NO>2</NO>
<PG>287</PG>
<PB>Academic Press Inc.</PB>
<IDENTIFIERS MODIFIED="2013-12-03 12:21:21 +0000" MODIFIED_BY="Amanda Nicholson">
<IDENTIFIER MODIFIED="2013-12-03 12:21:21 +0000" MODIFIED_BY="Amanda Nicholson" TYPE="EMBASE" VALUE="70651408"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-12-03 12:21:33 +0000" MODIFIED_BY="Amanda Nicholson"/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<ADDITIONAL_REFERENCES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<REFERENCE ID="REF-Bendixen-1963" MODIFIED="2009-06-26 12:38:29 +0100" MODIFIED_BY="Jane Cracknell" NAME="Bendixen 1963" TYPE="JOURNAL_ARTICLE">
<AU>Bendixen HH, Hedley-Whyte J, Laver MB</AU>
<TI>Impaired oxygenation in surgical patients during general anaesthesia with controlled ventilation</TI>
<SO>New England Journal of Medicine</SO>
<YR>1963</YR>
<VL>269</VL>
<PG>991-6</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:38:29 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:38:29 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="14059732"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Canet-1991" MODIFIED="2009-07-02 12:35:39 +0100" MODIFIED_BY="[Empty name]" NAME="Canet 1991" TYPE="JOURNAL_ARTICLE">
<AU>Canet J, Ricos M, Vidal F</AU>
<TI>Postanesthetic hypoxemia and oxygen administration</TI>
<SO>Anesthesiolgy</SO>
<YR>1991</YR>
<VL>74</VL>
<PG>1161-2</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:44:20 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:44:20 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE=" 2042775"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Caplan-1990" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Caplan 1990" TYPE="JOURNAL_ARTICLE">
<AU>Caplan RA, Posner KL, Ward RJ, Cheney FW</AU>
<TI>Adverse respiratory events in anesthesia: a closed claim analysis</TI>
<SO>Anesthesiology</SO>
<YR>1990</YR>
<VL>72</VL>
<PG>828-33</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:39:04 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:39:04 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="2339799"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cooper-1984" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Cooper 1984" TYPE="JOURNAL_ARTICLE">
<AU>Cooper JB, Newbower RS, Kitz RJ</AU>
<TI>An analysis of major errors and equipment failures in anesthesia management: considerations for prevention and detection</TI>
<SO>Anesthesiology</SO>
<YR>1984</YR>
<VL>60</VL>
<PG>34-42</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:39:34 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:39:34 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="6691595 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cooper-1987" MODIFIED="2009-06-26 12:40:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Cooper 1987" TYPE="JOURNAL_ARTICLE">
<AU>Cooper JB, Cullen DJ, Nemeskal R, Hoaglin DC, Gevirtz CC, Csete M, et al</AU>
<TI>Effects of information feedback and pulse oximetry on incidence of anesthesia complications</TI>
<SO>Anesthesiology</SO>
<YR>1987</YR>
<VL>67</VL>
<PG>686-94</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:40:06 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:40:06 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="3674468"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cote-1988" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Cote 1988" TYPE="JOURNAL_ARTICLE">
<AU>Cote CJ, Goldstein EA, Cote MA, Hoaglin DC, Ryan JF</AU>
<TI>A single-blind study of pulse oximetry in children</TI>
<SO>Anesthesiology</SO>
<YR>1988</YR>
<VL>68</VL>
<PG>184-8</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:40:32 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:40:32 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE=" 3277484"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cote-1991" MODIFIED="2009-06-26 12:41:01 +0100" MODIFIED_BY="Jane Cracknell" NAME="Cote 1991" TYPE="JOURNAL_ARTICLE">
<AU>Cote CJ, Rolf N, Liu LM, Goudsouzian NG, Ryan JF, Zaslavsky A, et al</AU>
<TI>A single-blind study of combined pulse oximetry and capnography in children</TI>
<SO>Anesthesiology</SO>
<YR>1991</YR>
<VL>74</VL>
<PG>980-7</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:41:01 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:41:01 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="1904206"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2008" MODIFIED="2013-11-21 11:29:53 +0000" MODIFIED_BY="Amanda Nicholson" NAME="Guyatt 2008" TYPE="OTHER">
<AU>Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ</AU>
<TI>What is "quality of evidence" and why is it important to clinicians?</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>336</VL>
<NO>7651</NO>
<PG>995-8</PG>
<EN>2008/05/06</EN>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18456631"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-02-17 11:36:45 +0000" MODIFIED_BY="Amanda Nicholson" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al</AU>
<TI>The Cochrane Collaboration&#8217;s tool for assessing risk of bias in randomised trials</TI>
<SO>BMJ</SO>
<YR>2011</YR>
<VL>343</VL>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="22008217"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Krasheninnikoff-1993" MODIFIED="2009-07-02 12:34:23 +0100" MODIFIED_BY="[Empty name]" NAME="Krasheninnikoff 1993" TYPE="JOURNAL_ARTICLE">
<AU>Krasheninnikoff M, Ellitsgaard N, Rude C, Moller JT</AU>
<TI>Hypoxaemia after osteosynthesis of hip fractures</TI>
<SO>International Orthopaedics</SO>
<YR>1993</YR>
<VL>17</VL>
<NO>1</NO>
<PG>27-9</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:41:29 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:41:29 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="8449619 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Laver-1964" MODIFIED="2009-06-26 12:41:55 +0100" MODIFIED_BY="Jane Cracknell" NAME="Laver 1964" TYPE="JOURNAL_ARTICLE">
<AU>Laver MB, Morgan J, Bendixen HH, Radford EP</AU>
<TI>Lung volume, compliance, and arterial oxygen tensions during controlled ventilation</TI>
<SO>Journal of Applied Physiology</SO>
<YR>1964</YR>
<VL>19</VL>
<PG>725-33</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:41:55 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:41:55 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="14195585"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mlinaric-1997" MODIFIED="2009-07-02 12:39:37 +0100" MODIFIED_BY="[Empty name]" NAME="Mlinaric 1997" TYPE="JOURNAL_ARTICLE">
<AU>Mlinaric J, Nincevic N, Kostov D, Gnjatovic D</AU>
<TI>Pulse oximetry and capnometry in the prevention of perioperative morbidity and mortality</TI>
<SO>Lijecnicki Vjesnik</SO>
<YR>1997</YR>
<VL>119</VL>
<PG>113-6</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:42:23 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:42:23 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE=" 9490372"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moller-1998" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Moller 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al</AU>
<TI>Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD Investigators. International Study of Post-Operative Cognitive Dysfunction</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>351</VL>
<PG>857-61</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:42:51 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:42:51 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="9525362"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-M_x00f8_ller-1994" MODIFIED="2009-06-26 12:44:56 +0100" MODIFIED_BY="Jane Cracknell" NAME="Møller 1994" TYPE="JOURNAL_ARTICLE">
<AU>Møller JT</AU>
<TI>Anesthesia related hypoxemia. The effect of pulse oximetry monitoring on perioperative events and postoperative complications</TI>
<SO>Danish Medical Bulletin</SO>
<YR>1994</YR>
<VL>41</VL>
<NO>5</NO>
<PG>489-500</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:44:56 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:44:56 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="7859517 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nunn-1965" MODIFIED="2009-06-26 12:45:00 +0100" MODIFIED_BY="Jane Cracknell" NAME="Nunn 1965" TYPE="JOURNAL_ARTICLE">
<AU>Nunn JF, Bergman NA, Coleman AJ, Jones DD</AU>
<TI>Factors influencing the arterial oxygen tension during anaesthesia with artificial ventilation</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1965</YR>
<VL>37</VL>
<PG>898-914</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pedersen-1994" MODIFIED="2009-06-26 12:46:43 +0100" MODIFIED_BY="Jane Cracknell" NAME="Pedersen 1994" TYPE="JOURNAL_ARTICLE">
<AU>Pedersen T</AU>
<TI>Complications and death following anaesthesia. A prospective study with special reference to the influence of patient-, anaesthesia-, and surgery-related risk factors</TI>
<SO>Danish Medical Bulletin</SO>
<YR>1994</YR>
<VL>41</VL>
<NO>3</NO>
<PG>319-31</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:45:48 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:45:48 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="7924461"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-5.2" MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Amanda Nicholson" NAME="RevMan 5.2" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rheineck-1996" MODIFIED="2009-06-26 12:47:06 +0100" MODIFIED_BY="Jane Cracknell" NAME="Rheineck 1996" TYPE="JOURNAL_ARTICLE">
<AU>Rheineck-Leyssius AT, Kalkman CJ, Trouwborst A</AU>
<TI>Influence of motivation of care providers on the incidence of postoperative hypoxaemia in the recovery room</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1996</YR>
<VL>77</VL>
<PG>453-7</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:47:06 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:47:06 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE=": 8942327"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Severinghaus-1992" MODIFIED="2009-06-26 12:47:33 +0100" MODIFIED_BY="Jane Cracknell" NAME="Severinghaus 1992" TYPE="JOURNAL_ARTICLE">
<AU>Severinghaus JW, Kelleher JF</AU>
<TI>Recent developments in pulse oximetry</TI>
<SO>Anesthesiology</SO>
<YR>1992</YR>
<VL>76</VL>
<PG>1018-38</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:47:33 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:47:33 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="1599088"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Shah-2013" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Shah 2013" TYPE="JOURNAL_ARTICLE">
<AU>Shah A, Shelley KH</AU>
<TI>Is pulse oximetry an essential tool or just another distraction? The role of the pulse oximeter in modern anesthesia care</TI>
<SO>Journal of Clinical Monitoring and Computing</SO>
<YR>2013</YR>
<VL>27</VL>
<NO>3</NO>
<PG>235-42</PG>
<IDENTIFIERS MODIFIED="2013-11-26 11:23:34 +0000" MODIFIED_BY="Amanda Nicholson">
<IDENTIFIER TYPE="PUBMED" VALUE="23314807"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stausholm-1997" MODIFIED="2009-06-26 12:47:59 +0100" MODIFIED_BY="Jane Cracknell" NAME="Stausholm 1997" TYPE="JOURNAL_ARTICLE">
<AU>Stausholm K, Rosenberg-Adamsen S, Edvardsen L, Kehlet H, Rosenberg J</AU>
<TI>Validation of pulse oximetry for monitoring of hypoxaemic episodes in the late postoperative period</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1997</YR>
<VL>78</VL>
<PG>86-7</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:47:59 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:47:59 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="9059211 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tinker-1989" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Tinker 1989" TYPE="JOURNAL_ARTICLE">
<AU>Tinker JH, Dull DL, Caplan RA, Ward RJ, Cheney FW</AU>
<TI>Role of monitoring devices in preventing of anesthetic mishaps: a closed claims analysis</TI>
<SO>Anesthesiology</SO>
<YR>1989</YR>
<VL>71</VL>
<PG>541-6</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:48:23 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:48:23 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="2508510"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Townes-1989" MODIFIED="2009-06-26 12:49:04 +0100" MODIFIED_BY="Jane Cracknell" NAME="Townes 1989" TYPE="JOURNAL_ARTICLE">
<AU>Townes BD, Bashein G, Hornbein TF, Coppel DB, Goldstein DE, Davis KB, et al</AU>
<TI>Neurobehavioral outcomes in cardiac operations</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1989</YR>
<VL>98</VL>
<PG>774-82</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:49:04 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:49:04 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="2811413"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Pedersen-2003a" MODIFIED="2009-06-26 12:25:05 +0100" MODIFIED_BY="Jane Cracknell" NAME="Pedersen 2003a" TYPE="COCHRANE_REVIEW">
<AU>Pedersen T, Dyrlund Pedersen B, Møller AM</AU>
<TI>Pulse oximetry for perioperative monitoring</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2009-06-10 14:09:34 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-10 14:09:34 +0100" MODIFIED_BY="Jane Cracknell" TYPE="DOI" VALUE="10.1002/14651858.CD002013"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pedersen-2003b" MODIFIED="2009-06-26 12:49:32 +0100" MODIFIED_BY="Jane Cracknell" NAME="Pedersen 2003b" TYPE="JOURNAL_ARTICLE">
<AU>Pedersen T, Dyrlund Pedersen B, Møller AM</AU>
<TI>Pulse oximetry for perioperative monitoring: systematic review of randomized trials</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2003</YR>
<VL>96</VL>
<PG>426-31</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:49:32 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:49:32 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="12917918 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pedersen-2003c" MODIFIED="2009-07-02 12:42:16 +0100" MODIFIED_BY="[Empty name]" NAME="Pedersen 2003c" TYPE="JOURNAL_ARTICLE">
<AU>Poulsen A, Pedersen T</AU>
<TI>Pulse oximetry in perioperative monitoring</TI>
<SO>Ugeskrift for Laeger</SO>
<YR>2003</YR>
<VL>165</VL>
<NO>42</NO>
<PG>4025-7</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:49:55 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:49:55 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="14610837"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pedersen-2005" MODIFIED="2009-06-26 12:50:22 +0100" MODIFIED_BY="Jane Cracknell" NAME="Pedersen 2005" TYPE="JOURNAL_ARTICLE">
<AU>Pedersen T</AU>
<TI>Does perioperative pulse oximetry improve outcome? Seeking the best available evidence to answer the clinical question</TI>
<SO>Best Practice and Research. Clinical Anaesthesiology</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>1</NO>
<PG>111-23</PG>
<IDENTIFIERS MODIFIED="2009-06-26 12:50:22 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-06-26 12:50:22 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="15679062 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pedersen-2009" MODIFIED="2013-12-17 19:43:16 +0000" MODIFIED_BY="Jane Cracknell" NAME="Pedersen 2009" TYPE="COCHRANE_REVIEW">
<AU>Pedersen T, Hovhannisyan K, Møller AM</AU>
<TI>Pulse oximetry for perioperative monitoring</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-12-09 18:35:57 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2013-12-09 18:35:57 +0000" MODIFIED_BY="Jane Cracknell" TYPE="DOI" VALUE="10.1002/14651858.CD002013.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" SORT_BY="STUDY" USER_DEF_1_ENABLED="YES" USER_DEF_1_NAME="Other monitoring" USER_DEF_2_ENABLED="YES" USER_DEF_2_NAME="Location and duration of monitoring" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Bierman-1992">
<CHAR_METHODS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Single-centre RCT. Cardiac ICU, University Hospital, Pittsburgh, USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>35 participants undergoing cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>
<U>Intervention group</U>: N = 20. Pulse oximetry (NellcorN-200) by bedside. Finger/earlobe probe. Alarms on. Continuous access and monitoring in lieu of blood gases but blood gases whenever required, at least each morning<BR/>
<U>Control group</U>: N = 15. Pulse oximetry (NellcorN-200). Finger/earlobe probe. Readout by bedside masked and data transmitted to remote site. Blood gases at least every six hours. Bedside nurse notified of hypoxic episodes &lt; 90% SpO<SUB>2 </SUB>&gt;<I>
<B> 5</B>
</I> minutes or SpO<SUB>2 </SUB>between 90% and 93% lasting &gt; 10 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-03-10 12:49:58 +0000" MODIFIED_BY="[Empty name]">
<P>Clinically undetected hypoxic episodes &lt; 94%</P>
<P>Number of blood gas analyses</P>
<P>Length of stay in ICU</P>
<P>Changes in ventilator support and blood gas</P>
<P>.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Continuous arterial BP, pulmonary art pressure, ECG and mixed venous saturation monitoring</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2014-03-10 12:49:56 +0000" MODIFIED_BY="[Empty name]">
<P>Participants monitored from arrival on cardiac ICU. Not clear how long monitoring continued</P>
</CHAR_USER_DEF_2>
<CHAR_NOTES MODIFIED="2013-11-26 11:43:46 +0000" MODIFIED_BY="Amanda Nicholson"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Moller-1992a">
<CHAR_METHODS MODIFIED="2014-03-10 12:50:51 +0000" MODIFIED_BY="[Empty name]">
<P>Two-centre RCT: one teaching hospital and one major hospital in Denmark</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-10 12:50:51 +0000" MODIFIED_BY="[Empty name]">
<P>200 adult participants undergoing elective surgery expected to last longer than 20 minutes and performed under general, spinal or epidural anaesthesia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Intervention group: N = 100. Available pulse oximetry (Radiometer/Ohmeda). Alarms on. Finger probe</P>
<P>Control group: N = 100. Pulse oximetry (Radiometer/Ohmeda) in sealed box. Data stored. Alarms off. Finger probe</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-03-10 12:51:12 +0000" MODIFIED_BY="[Empty name]">
<P>Episodes of hypoxia: mild 86% to 90% oxygen saturation, moderate 81% to 85%; severe 76% to 80%; extreme &lt; 76%</P>
<P>Time spent hypoxic &lt; 90% SpO<SUB>2</SUB>
</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2014-03-14 10:10:41 +0000" MODIFIED_BY="Jane Cracknell">
<P>OR: ECG, arterial pressure every<I>
<B> </B>
</I>5<I>
<B> </B>
</I>minutes, central venous pressure (CVP) if indicated</P>
<P>Recovery ECG and CVP continuous BP, HR and respiratory rate every 15 minutes</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Monitoring in OR and in recovery room. From arrival in OR to discharge from recovery room or after six hours if still in recovery room</P>
</CHAR_USER_DEF_2>
<CHAR_NOTES MODIFIED="2014-03-10 12:50:52 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Moller-1993b">
<CHAR_METHODS MODIFIED="2014-03-10 12:52:25 +0000" MODIFIED_BY="[Empty name]">
<P>Two-centre cluster-randomized RCT: one teaching hospital and one major hospital in Denmark</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-10 12:52:42 +0000" MODIFIED_BY="[Empty name]">
<P>736 adult participants undergoing elective surgery expected to last longer than 20 minutes and performed under general, spinal or epidural anaesthesia. Each day, four participants from each surgical department selected for cognitive testing</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-10 12:52:42 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention group: N = 358. pulse oximetry (Radiometer/Ohmeda). Intervene if SpO<SUB>2</SUB>&lt; 93%. Finger probe<BR/>Control group: N = 378. Not monitored by pulse oximetry at any time</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Incidence of hypoxia during anaesthesia defined as cyanosis, arterial oxygen &lt; 7.8 kPa, SaO<SUB>2 </SUB>&lt; 90%<SUB>,</SUB> or SpO<SUB>2 </SUB>&lt; 90%</P>
<P>
<B>Changes to patient care</B>
</P>
<P>Cognitive function (Wechsler memory scale): preoperatively, POD7. Participants with score decreased by 10 or more points were tested again after three months</P>
<P>Participant&#8211;reported assessment of whether cognitive abilities had changed following anaesthesia at six weeks postoperatively</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>OR: ECG, arterial pressure every<B> </B>5<B> </B>minutes, CVP if indicated</P>
<P>Recovery room -ECG &amp; CVP continuously. BP, HR &amp; respiratory rate every 15 minutes.</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Monitoring in the operating theatre and in the recovery room. Monitored from just before induction until discharge from recovery room</P>
</CHAR_USER_DEF_2>
<CHAR_NOTES MODIFIED="2014-03-10 12:52:25 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Moller-1993c">
<CHAR_METHODS MODIFIED="2014-03-10 12:55:49 +0000" MODIFIED_BY="[Empty name]">
<P>Multi-centre cluster-randomized RCT, three teaching hospitals and two major hospitals in Denmark</P>
<P>Not blinded, elective participants were assigned to an operating room the day before surgery, and pulse oximeters were assigned to operating rooms randomly</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-10 12:55:57 +0000" MODIFIED_BY="[Empty name]">
<P>20,802 adult participants undergoing elective surgery expected to last longer than 20 minutes and performed under general, spinal or epidural anaesthesia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Intervention group: N = 10,312. Pulse oximetry (Radiometer/Ohmeda). Intervene if SpO<SUB>2</SUB> &lt; 93%. Finger probe</P>
<P>Control group: N = 10,490. No monitoring</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>Incidence of hypoxia during anaesthesia defined as cyanosis, arterial oxygen &lt; 7.8 kPa, SaO<SUB>2 </SUB>&lt; 90% or SpO<SUB>2 </SUB>&lt; 90%</P>
<P>
<B>Events during monitoring:</B>
</P>
<P>Changes to patient<I>
<B> </B>
</I>care</P>
<P>Postoperative complications: respiratory, cardiovascular, neurological and infectious; duration of recovery room stay and ICU admittance. At POD7 or discharge</P>
<P>Death</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<P>OR: ECG, arterial pressure every<I>
<B> </B>
</I>5 minutes, CVP if indicated</P>
<P>Recovery room: ECG and CVP continuously. BP, HR and respiratory rate every 15 minutes</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2014-03-10 12:56:50 +0000" MODIFIED_BY="[Empty name]">
<P>Participants assigned a pulse oximeter were monitored from just before induction of anaesthesia until discharge from the PACU</P>
</CHAR_USER_DEF_2>
<CHAR_NOTES MODIFIED="2013-11-25 15:49:13 +0000" MODIFIED_BY="Amanda Nicholson"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-10 12:58:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ochroch-2006">
<CHAR_METHODS MODIFIED="2014-03-10 12:58:56 +0000" MODIFIED_BY="[Empty name]">
<P>Single-centre RCT. University hospital, Philadelphia, USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-10 12:58:57 +0000" MODIFIED_BY="[Empty name]">
<P>1219 participants recovering from cardiac and thoracic surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-10 12:58:57 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention group: N = 589. Continuous monitoring using Nellcor central station network CPOX system Oxinet II via telemetry station</P>
<P>Control group: N = 630. Intermittent assessment as nurse required. Standalone monitors available. &#8220;Typical use"</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-03-10 12:58:57 +0000" MODIFIED_BY="[Empty name]">
<P>Admission to ICU</P>
<P>Reason for transfer</P>
<P>Length of stay in ICU</P>
<P>Costs of hospital stay</P>
<P>In-hospital mortality</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2013-11-21 15:13:12 +0000" MODIFIED_BY="Amanda Nicholson">
<P>Concurrent continuous ECG telemetry</P>
</CHAR_USER_DEF_1>
<CHAR_USER_DEF_2 MODIFIED="2014-03-10 12:58:56 +0000" MODIFIED_BY="[Empty name]">
<P>Surgery care ward&#8212;telemetry station. USA. Monitored from admission to discharge/transfer to ICU/other ward</P>
</CHAR_USER_DEF_2>
<CHAR_NOTES MODIFIED="2014-03-10 12:58:57 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ICU: Intensive care unit.<BR/>N: Numbers.<BR/>PACU: Postanaesthesia care unit.</P>
<P>CVP: Central venous pressure.</P>
<P>OR: Operating room.</P>
<P>BP: Blood pressure.</P>
<P>HR: Heart rate.</P>
<P>SpO<SUB>2 </SUB>(%): Saturation level of oxygen in haemoglobin, estimated from pulse oximetry.</P>
<P>SaO<SUB>2 </SUB>(%):<SUB> </SUB>Saturation level of oxygen in haemoglobin, measured in arterial blood.</P>
<P>PaO<SUB>2</SUB>:<SUB> </SUB>Partial pressure of oxygen in arterial blood.</P>
<P>POD: Postoperative day. Day of surgery = POD0<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2014-03-10 13:00:04 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2014-03-10 12:59:38 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cullen-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-10 12:59:38 +0000" MODIFIED_BY="[Empty name]">
<P>A non-randomized study of 17,093 surgical participants expected to enter the recovery room and then return to floor care. During the first 28 weeks of the study, only seven pulse oximeters were available for shared use in 51 ORs. For the subsequent 37 weeks, pulse oximeters were placed and were used on essentially all participants in all 51 anaesthetizing locations</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-03-10 12:59:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mateer-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-10 12:59:57 +0000" MODIFIED_BY="[Empty name]">
<P>A non-randomized study of 191 consecutive adult participants to determine whether pulse oximetry improves recognition of hypoxaemia during emergency endotracheal intubation. An observation period of complications lasted only five minutes after intubation, and no events or complications were observed during anaesthesia or in the postoperative period</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>min: Minutes.<BR/>OR: Operating room.<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-03-10 13:00:09 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2014-03-10 13:00:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haines-2012">
<CHAR_METHODS MODIFIED="2014-03-10 13:00:09 +0000" MODIFIED_BY="[Empty name]">
<P>Published in abstract only. Unclear design. May not be a randomized trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-10 13:00:09 +0000" MODIFIED_BY="[Empty name]">
<P>32 participants undergoing bariatric surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-11-21 12:18:37 +0000" MODIFIED_BY="Amanda Nicholson">
<P>Continuous pulse oximetry in 24 hours postoperatively versus intermittent pulse oximetry</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-21 12:15:41 +0000" MODIFIED_BY="Amanda Nicholson">
<P>Episodes of hypoxaemia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-10 13:00:09 +0000" MODIFIED_BY="[Empty name]">
<P>Study author emailed on 30/9/2013</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>"patients were randomly assigned". No further details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION>
<P>"patients allocated randomly to two group(s)". No further details given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>ORs were cluster-randomized on a daily basis after participants had been assigned. No details of randomization method</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-10 12:56:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>ORs were cluster-randomized on a daily basis after participants had been assigned. No details of randomization method</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>"randomly generated group assignments". No further details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>"patients were randomly assigned". No further details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION>
<P>"patients allocated randomly to two group(s)". No further details given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Allocation sent in sealed envelope after allocation of participants. No possibility of changing participants. For emergency cases, an envelope containing the random assignment was drawn from a stack</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-10 12:56:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Allocation sent in sealed envelope after allocation of participants. No possibility of changing participants. For emergency cases, an envelope containing the random assignment was drawn from a stack</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-21 15:14:56 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>"Sequential sealed envelopes". No further details</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-11-21 13:42:10 +0000" MODIFIED_BY="Jane Cracknell" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.04" NO="4">
<NAME>ICU admission</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.03" NO="3">
<NAME>Complications/mortality/cognitive function</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.02" NO="2">
<NAME>Interventions</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>Hypoxaemia</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-11-21 13:47:35 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-11-21 13:47:41 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.03" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.04" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.03" MODIFIED="2013-11-21 14:30:34 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.04" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-11-21 14:29:09 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-11-25 13:57:15 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.03" MODIFIED="2013-11-21 14:29:15 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.04" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-11-21 14:55:42 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2013-11-21 14:55:44 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.03" MODIFIED="2013-11-21 14:55:46 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.04" MODIFIED="2014-03-10 12:57:00 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-03-10 12:59:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.02" MODIFIED="2014-03-10 12:59:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.03" MODIFIED="2013-12-06 10:47:43 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.04" MODIFIED="2013-11-21 15:15:24 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="NO" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>Staff responded to available data and modified treatment accordingly</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>Hypoxaemia</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.02" NO="2">
<NAME>Interventions</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.03" NO="3">
<NAME>Complications/mortality/cognitive function</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.04" NO="4">
<NAME>ICU admission</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>Same monitors used in intervention and control groups. Trend recordings printed every 12 hours and examined to determine number and duration of desaturations to &lt; 94%</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>Not clear whether information on interventions was based on automated data or was manually recorded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.03" MODIFIED="2013-11-26 11:43:54 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.04" MODIFIED="2013-11-26 11:43:54 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION>
<P>Same monitors in use in intervention and control groups. Data stored electronically</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.03" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.04" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-10 12:55:01 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Hypoxia detection differed in intervention and control groups and was recorded by OR personnel who were not blinded to participant allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Changes in care recorded by OR personnel who were not blinded to participant allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.03" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Nurses undertaking cognitive function testing unaware of allocation.<I>
<B> </B>
</I>Patient reported outcome unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.04" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Hypoxia recorded by OR personnel (form A). These staff members were not blinded, and methods for detecting hypoxaemia differed in the two groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Changes in care recorded by OR personnel (form A). These staff members were not blinded to allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.03" MODIFIED="2013-11-21 15:00:45 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="YES" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Form B for complications completed by staff unaware of allocation. Standardized definitions for complications</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.04" MODIFIED="2014-03-10 12:57:00 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-10 12:59:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.02" MODIFIED="2014-03-10 12:59:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.03" MODIFIED="2013-11-25 16:33:21 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="YES" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>In-hospital mortality at low risk of bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.04" MODIFIED="2014-03-10 12:59:15 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>No standardized admission criteria. Blinded chart review, but staff completing charts were not blinded. Reasons for admissions differed between groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>1<I>
<B>/</B>
</I>21 withdrawn from intervention group because of cardiovascular problems</P>
<P>3/18 withdrawn from control group: two for problems with telemetry and one because of respiratory problems</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-14 10:10:56 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION>
<P>4/104 in intervention group &amp; 2<I>
<B>/</B>
</I>102 in control group excluded because of lack of co-operation or poor peripheral perfusion</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>125/861 (14.6%) participants did not complete study, but equally distributed between intervention and control groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-10 12:57:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>938/21,740 excluded: 366 because participant was receiving a second anaesthetic during admission, 475 for randomizing errors. Exclusions were equally distributed between control and intervention groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-10 12:59:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>No apparent losses</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-12-06 10:45:24 +0000" MODIFIED_BY="Jane Cracknell" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-06 10:45:24 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="YES" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>All outcomes specified in Methods reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-21 14:09:30 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="YES" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION>
<P>All outcomes specified in Methods reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-21 14:33:10 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="YES" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>All outcomes specified in Methods reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-21 15:03:10 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="YES" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>All outcomes specified in Methods reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-21 15:17:05 +0000" MODIFIED_BY="Amanda Nicholson" RESULT="YES" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>All outcomes specified in Methods reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Bierman-1992">
<DESCRIPTION>
<P>Nellcor loaned telemetry system and two pulse oximeters</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:11:03 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1992a">
<DESCRIPTION>
<P>Ohmeda and Radiometer provided meters for the study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993b">
<DESCRIPTION>
<P>Statistical methods have not allowed for clustering</P>
<P>Ohmeda and Radiometer provided meters for study</P>
<P>Many other funders listed. None obviously commercial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Moller-1993c">
<DESCRIPTION>
<P>Statistical methods have not allowed for clustering</P>
<P>Ohmeda and Radiometer provided meters for study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-10 12:59:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ochroch-2006">
<DESCRIPTION>
<P>Only 1219 of a total of 8300 potential participants enrolled. Not clear why so many participants not enrolled, possibly related to nurse staffing levels</P>
<P>Study funded by Nellcor&#8212;unrestricted grant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="1" READONLY="YES">
<TITLE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">Continuous pulse oximetry versus no/intermittent pulse oximetry for perioperative monitoring</TITLE>
<TABLE COLS="7" ROWS="11">
<TR>
<TD COLSPAN="7">
<P>
<B>Continuous pulse oximetry versus no/intermittent pulse oximetry for perioperative monitoring</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients undergoing surgery requiring anaesthesia<BR/>
<B>Settings:</B>
<BR/>
<B>Intervention:</B> continuous pulse oximetry versus no/intermittent pulse oximetry<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No. of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Continuous pulse oximetry versus no/intermittent pulse oximetry</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Episodes of hypoxaemia (SpO2 &lt; 90%)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>235<BR/>(two studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Results not pooled. Significantly lower incidence of hypoxaemia in oximetry group in OR and in recovery room</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Changes to patient care</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>21,037<BR/>(three studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Results not pooled. Two studies showed increased numbers of changes in ventilatory support and increased oxygen in oximetry group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Complications</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20,802<BR/>(one study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No reduction seen in number of cardiovascular, respiratory, neurological or infectious complications</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>In-hospital mortality</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>22,021<BR/>(two studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Results not pooled. No difference in mortality between oximetry and control groups</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>OR:</B> Odds ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence.<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2008-01-16 11:53:49 +0000" MODIFIED_BY="Karen Hovhannisyan"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES MODIFIED="2014-03-14 10:15:09 +0000" MODIFIED_BY="Jane Cracknell">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Search results.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAhAAAAM4CAYAAACdiNtmAACAAElEQVR42uy9D2SX3////ybJTCYm
M5nEzPSZmZEkSWImSWbMvCR5iWQymXiZZJJIJjMTmWQmkWSSGZm8JImXmUkyJkkyMZlkcn6/++E8
v+d57fr73HPb87ndbjxt179zXec653o87udxznWd/xmP//3vf/z48eNX8r9SgzLhtx2fnf/5DwAA
QDlQSvYK2wnb9dn5Hw8AACAiEA/As1NAOjwAAICIQDwAzw4CAgAwgggIAAQEAAACAgABAQCAgABA
QAAAICAAEBAAAAgIBATw7CAgAAAjiIAA2EAB4X+5aseOHaaiosKcOHHCzM3NZTrBmzdvzPHjxzNn
jIfTbNg9a29vX3Vsmi+ZjY+Pm4aGBrNz505TXV1trly5Yn7+/Lkq/c+fP5vdu3dTprBtBMTi4qK5
dOmSfS70fNTU1JirV6+aHz9+JNpH7N/WI62t3JICwv/t2bPHfPnyZV0dGw/QxgiIDx8+mJMnT4Ye
G1X+f//9t93+7Nmz0O1dXV2rznPkyBHKFLaNgJBjOHjwYOjz0dzcnOc44p492BpksZVbTkD4rci2
tja7rqenJ7d+YWHBKmhFKKSuWltbraqOckJJx/jHDQ8Pm71791r1PjIyknd9SWkoUnL06FG7Tfto
X+XBZ2xszNTX19t9mpqazMTEROzNKkaaafP+9u1bm3c5X8fo6Kipra01u3btMhcuXDArKyurjlNa
MlLaR9f66dOn2Ap06NChVAbrxo0bVjwuLS3ZZUWjdMzAwIBdfvHihV1Wvny0ff/+/RhF2DYC4vr1
63abRMTs7GzOdsgeaL22x9nHtM9ykq2JsyVZ7dqTJ09sfrSPWtJyikmiJ7iuUNuWJq9p8rBZpLWV
W1pAiI8fP9p1Bw4cyK2TAww+BKpgcQ9I3DFxrd9Hjx6lOq8IawHIWTpcIQZ/vjMPUow0s+b97Nmz
uQc4uE1OPXhcVVVV3j7Hjh2LzE9HR4cNqSY5969fv9rK7h4AoQdU3RLuQddfpSGx4Hj37p3t/nr9
+jUCAraNgHB2ImhL5DidsEgjIOKe5TS2JsqWZLVrL1++DD3Xq1evChIQWW1bmrwm5WEzSWMrt4WA
cOulEsOYn59ftT3JccQdo34iob8u/Jc2DTkurYtSoXoYtV0Ph5ienrbLnZ2dkdda7DTj8t7b25uL
WIjDhw/b9VLe6noICjl33OXLl82fP3/M1NRUapWbVEZ9fX0279+/f4/c59q1azYNGQOxvLxsWwxa
T1gWtpOAUCtY2/Qc+mg5jX1M8yynsTVRtiSrXZMD1PaLFy9a56e/QUGTRUBktW1p8pqUh1IiaCu3
nYDQA+IjJSgn09LSEllpgqQ5Ri1foTEXWc+rMJgbAKpQmRStP4BJD3GYqpVSjKJYaabJe/BBcEYp
SQTIcacVBmn2+/37t6msrDSnTp2KPF4GQccPDg7m3SuFGp3qRkAAAiKbgIh7ltPYmihbUqhdky1w
NiEoaLIIiKy2LU1ek/JQKoTZym0jINQHp3V1dXW5dRqnoHX9/f059ZgkINIe45yPhESwwialoWNV
ieT41LembeqLClba4E8VMIpipFnI/YozSlke4EIEhEYPR1V4PaBuXMydO3dC01zv+egBAVFq525s
bLTb1FL2cS1nReayPrfBdWlsTdrnLcmuBQWEIgdJAsKJjGLYtjR5TcrDZhNnK7eFgNANUMgoOIjS
vZ6nSjU5ORlZaX79+pVT1GmPkZP1VZs/6CYpDR+9UhWMYLixCOpfK4RC00yb9yAuzPf8+XM7MMv1
ka63gOju7rbbFEYNPhDqUtK24IAqBARsZwHhBlGqj/u///6z62ZmZnKDid0gyij7mOZZTmNrCnne
wuya60JQ14WcvOvC8F8/dU5e3QzaR90vxbJtWW11WB42WzzE2cotLSCSXuP0R9jrp3C3/rrR+opW
BF9bSTom6txPnz5NfV5XKf2fL0AeP34ceg6pxCiKkWbavAcJG2jkC7n1EhBqLfmtD4feac8iEBAP
sF0EhF7TdFGI4E/r/dc4w+xjmmc5ja1J+8wl2bWo1xA1ONqhNyCS7EGhti1NXpPysJlktZVbUkAo
XKVRs8EPSak/373eow8SuW4O3TRX+fQapra7Ak06xp1zaGjIHis1GnyNMykNdXvoLQP3uqQqW/D7
FXp1SA+0QmE6h1RzXL9ZMdJMm/cwdA/0+pN71SlpvEMxBERU/6TKBQEBCIjoVrAGfzvbp7+KpAbt
S5h9TPssJ9matM9cGrsmJ68xTdqucwajAeqOVaRA16IBkHpjLq2ASLJtafKaJg+bRVZbuSUEBAAA
AqI0zw2AgAAAQEAAICAAABAQAAgIAAAEBAICeHYQEACAEURAACAgAAAjiIAAQEAAACAgABAQAAAI
CAAEBAAAAgIBATw7CAgAwAgiIIBnBwEBABhBBAQAAgIAAAEBgIAAAEBAACAgAAAQEBQAICAAABAQ
CAjg2UFAAABGEAEBgIAAAEBAACAgAAAQEAAICAAABAQUn9nZ2W157i0hIBYXF01vb6/Zu3ev2blz
pzl48KAZHx9fdRFRP3+f4HHBDKRNx//pmnbv3m0uXbpkfv78uSr9V69e2f2mpqZ4+DeBa9eu2fKp
qKgwnZ2d5tu3b7ltS0tLsWXt8+TJE8oLykZAZLVTUbx48cIe29LSsuXKKm257dq1a92uJ+n+pjl3
lvq3XnV1eXnZ1q3Kykp7zbK1P3782FwBoYre2tpqRkdHze/fv+26d+/emf3795uHDx9mugjto7R+
/fqV+gFMu17X2dfXZy5fvrxq29mzZ+22M2fOICA2mDt37pihoSHz588f+7t586Y5fvx4bvvExISt
6El8/vzZHkd5QTkJiCx2Kgo5t5cvX27rslrP8k26v8U+93rl5cqVK2Z4eDhna9VwS2Nb11VAXL9+
3dy9e3fVeokIiYGsAuL+/fvmxo0bRRcQQjdN6svn69evZt++ffZ/iR6/9YuAWH8OHDhglXHwgXVI
UNy7dy8xnba2NvPx40fKC8paQETZqYGBAVNVVWXXK9obFcVI2t8d8/btWxsx9m100jFqJNbV1Zkd
O3ascqpqPJ47d85GERsaGsybN29SXX+WCISLBOj8TU1NZnp6OvIeRO0bhZyprk3Xr4bIly9fYu9v
3P0Pu7/+sfPz8+b06dP2XLpG3a9nz55lynMh7Nmzx9Ytx8rKStGjJ5kFRGNjo239FeMi3D6HDh3K
FWAxBYQIPphyUP/884/9v7+/31Z0BMTmoO4K3f/u7u7cuo6ODnPy5ElrfBTe1YMeRGWoKAblBVtB
QATt1MjIiHXeMv4y+urmvX37dmQ6afbv6emx29WASnuMnJ6zyxIPvtBXQ1JdiEJRQ/mFtNeTVkD4
omVyctI2PqLuQdy+QdQA9qOgul6JobR1J7g97P76+zQ3N5uxsbHc+XRuiY2seV4rEn3+eTdFQPiV
KOki0oxdEK9fvzZdXV1FFRASOYODg7ZgfaSopQjFwsKCjUIgIDYelbeMpn7//fdfbn1NTY159OhR
rmWmCJWMlR/pksCgvGArCIgwO6W+d7/l6CJ3Uemk2d9voBV6jH9eCYbg8WnTTisg5OycSEm6l3H7
BtGYPdf97hxrdXX1mgRE3L0KQxGGrHleK7Krvi3dFAGhMEyxHmB/HzkUCYlCBUTwV1tba1uvUsAO
KTq/v12cOHEibzAlDmljURkpVBeFDJFEhXDjb/xuJ8oLyklApLFTaqQF94tyOIXsX+gxwZZyFElp
pxUQstdaliBJ6uaO2zfOeYflpxABkbSPujjkvBVtlYApJM9rQS8+yMf69WxTBITCMd+/f1+1XhcW
1a+T5kKlxNWVsdYIhJxLe3u7mZmZWbWfQnJhD7HW45A2B9WbpKiWe+DPnz9vnj59SsQIyj4CEWen
4pxtWPpZ9y/0mLQCIinttALCOV51kWjMkwabxl1f1L5xYiHNNaxVQOjlAkVsHjx4YBur6uYoJM9r
sbF//fVXqN/ecAEhVaT+rbDwyJEjRwoWEC5thazX2oWhGyZR8Pz589w6hZjUfREMrWlZ612rFoe0
vihE51fkYPhQ//uvtGm7Bh1FteDiXvMEBESpCogoOyUUkdP4oLTpZ92/0GP8dfX19ZFdGElpF+K8
JbTSOvngvmHXF+zC8AcXFltAaCyXfz/UdV5InguNPOhVTp1zI5+dSAGh90gVgtHrIRpNr0qkVqFG
fLouiEIFhF7nVOimGGMgJAjU7+ZunMRJ2NsjQq8WusGUOKP1ReFalYUbUKQBrW5Qq7h69aotC7dd
g69U10rRUQACoth2SshO3bp1K/cMaNnveg2mk3X/Qo/x1ykcr3C70Hd1/EGUSWmnFRBKU28liOAg
TnWlq1HohEDcvmF515te7vpkXySI0tad4LmT7pUaqC46Pzc3ZyPtheQ5K//++685duzYqjcNN1VA
CHU3KCSiAXAKV6lfWpUoeBFpB1H6aMRusd7C0DXpBgp1vQS/N+GQEHL98LRy1xe1ujRgTIpf9Sf4
loXK6OLFi3a7RKkMUak6CkBAFNtOOfSGmFqueg4UpXCj+6PSybp/Icf46/Sc6psC7kOC79+/T512
WgGhUL7Sdq+ROscq1LBQ2i5yELdvVEPGDeLWGxifPn1KXXeC5066V2pYSyTquiQQgh/AS5vnrOhz
BYX4MT5lDQAIiG14boBSqL8ICABAQCAggGcHAQEAGEEEBAACAgAAAQGAgAAAQEAAICAAABAQAAgI
AAAEBAICeHYQEACAEURAACAgAAAQEAAlLiD0GU5/0iwffdLaTYjlLiTN1yiDP39O9LSZCqapL1om
7cMXJzeP4NfYhL4Xn6Y89BU8/9OzAAgIgDIQEFovkRD8LLS+C67PRWeZ1SxqH4kHfW/cFxFZBYQ+
rx28xqzXBuuDPoWub+MHy0Az0OnzuHHoU9gdHR2UHyAgAMpRQGjyKc2a6aPZODVJUjEEhBMRhc7R
rv91fXFzyPOQbx6apvbjx4+ryuDmzZt2kps4JDwkQCg/QEAAlKGA0Mxx/tTdUU5hrRN3FDpHu/tf
kRLNmoaAKB0kEoaGhkLLQJGFkydPmqqqKjsRT3CiLTE1NUX5AQICoFwFhJCAkGAQmi5U3RdhTrqQ
GTmLJSA0C1pXV1fkPoyB2FjevXtnBUJUmdbU1NhIltA0u4oiadpgjDQgIAC2kIBQqPmff/6x/w8O
DtopTgtp5a+ngBASEBISRCA2l58/f9pxKf7c9EllIBEhUYGRBgQEwBYSEJrfvba21hr5lpYW261R
igJC/eXuzRAExOZx/vx5+5ZO1oq6Y8cOjDQgIAC2koAQGtCmKMThw4cLcvpx+6x1EKWPBlMqHI6A
2NxKmdRlVF1dbSMVDr3Z09DQgJGGsnPi1E/Yzs9NKgExMjJiW4jqwiimgHjx4oV9jVN/iyEg9Dqn
oiQIiNKurFevXjUDAwM2qqWfusWGh4cx0FCWDpw6Ctv1mUklIH78+GEFhLozohx5MT8kFZdWkjjQ
h6UYRFnaFVZC7+LFi2bXrl1mz5495tatWxhnKGvnHWdn+PErpV+R6z0GGgAQEEDZAgICAHAyQNkC
AgIAACdD2QICAgAAJwOULQICAAAnA5QtAgIAACcDlC0gIAAAJwOULSAgAABwMpQtICAAAHAyQNlu
KQGR5ktWmrzq2bNnocdrQiU3uVVYevqEdVtbm/n06dOqY1+9emX3mZqaWrVNcyhcuXLFzqegL1ke
OHDAfhY567XD+rK0tJTq/uurlPX19aFp6Kui+/fvt1+sVF2amZnhxgJOhrKFchAQaQpYhl1OwEeT
IzU3N8d+dlr73Lx50xw8eHBVumfPnjV9fX3mzJkzq7Z1d3ebR48e2TkUXDrXrl2zPype6TAxMWE6
Oztj91lZWTEdHR2h5fXu3Ts7eZtmf1VZj42NmcbGRm4s4GQoW9gqAuLOnTt2BkwfOXjNjJlmUitF
Inw038a+ffvs/2p9fvv2LW+7P3OnH5XQnApUvNJB4vDevXux+2iWV03DHlZeEoqqWwA4GcoWtqiA
UAvxyJEjeevVNfHx48dYAaFWpSZRunv37irHo6nDRX9//6ruCbVCNXujIg9UvNJFkYWTJ0+aqqoq
s3v37rwIkcN1UYWVV11dnZmdneVGAk6GsoVyFBBpZtgUEhASDEIRA3VfBCtAVFqKVgQdx/z8vP1f
4kRRCJ/379/bcQ+KRJw6dcpGP16/fp352mF9qampyZWtxKLK6fr166kNhcp3cnLSNDQ02CiVukM0
KywAToayhS0SgRAKVbuoweDgoI0QhAmIYARC/dpyEA45DIW1fU6cOBE6mPLt27f2XKdPn7bOxg93
U/FKD5W3REXauqZ1ly5dsoMxdezIyIjt1gDAyVC2sIUEhMYt1NbWWkPf0tJiIwdJAsKhEfYOiYGw
qIHWx6FQt6ISVLzSZseOHanrmro9/G4q1S2/rgDwrFO2sAUEhFDkQFEIjZwP2x6Wnkbh63VM8eXL
F9t94d6u8B2H1rvBlBosGdxHVFZWUvFKCJWrBrc6JAb8aFNSXWtvb19VD4IDbgF41ilb2AICQiFm
tTDVrZBGQOjVTwkOva4p9NZGcEClQ90TbjClBuNpP43ed+moC6Wnp4eKV0JcvXrVlpkcv37q1hoe
Hk5d1548eWJ/7niVsf9dEQCedcoWSlhApB1EKTTATQJC3RlRAsL/KZIgp+++IaGBl8HvSTiWl5dN
U1NTblmOSR8f0vnU0pWo8MPdDKLcfFSWFy9etN0OKmu9cZPVUEg07N2716ahbiw3UBcAJ0PZQgkL
CAAAnAxQtoCAAACcDFC2gIAAAMB+UbaAgAAAwMkAZYuAAADAyQBli4AAAMDJAGULCAgAwMkAZQsI
CADAyQBlCwgIAACcDGULZSwgFhcXTW9vr/0aoGa8PHjwoBkfH48sZP0f3B5VEV69emXXh820mebz
2lSu0kbzYJw7d85+RVJfC1U9CpuOW1+s1FdFAXAyQNluEQEhB9Da2mpGR0dzn4l+9+6d2b9/v3n4
8GGkU9cxwU9Sh53j7Nmzdh6MM2fOICC2IPqMtea/8Oey6OjoyNtHk6lpHWUJOBmgbLeQgLh+/Xro
5FYSERIJUU79/v37dmKsuIqg+TL27dtn/5cgcTNtIiC2Doo8+LOm6n9N0e2jGVw1KRplCTgZoGy3
kIBobGzMzXiZtpDd/5o1UdNzR1WEmzdv2pk4RX9/f26mTQTE1hUQimJpnY/rvqIsAScDlO0WEhAa
85C1kN3/r1+/Nl1dXZEVoa6uzszPz9v/FxYWbBQimGaWmUCh9ND4B3VbSESoS+vKlSt29lQMBeBk
gLLd4gKioqKiYAEhJCAkJILrJycnbeja58SJE3mDKYlAlD8aMKk6ICGqQZIq92AEgrIEnAxQtltQ
QDQ3N5vv37+vWq+Bb8+ePUt06ur+UFdGcP3p06dDIwtaj4DYuszNzZna2loMBeBkgLLd6gJCAyH1
BkaQR48emSNHjqRy6kpDgyrdeo2LUPeF3zcutKz1bjAlAmLr8fTpU9Pd3Y2hAJwMULZbXUAoBK3v
PgwPD5vl5WXr5OUE9uzZk+uaSHLq6vtuaWnJrZegCHuzQ9y5cyc3mBIBUf5oEK7qi9B4l7a2NvP+
/XsMBeBkgLLd6gJCqBvir7/+MpWVlXYAnF7f1Aegsjh1fVjKrVe3SPAbEQ6JlKampkwCImmgJWwe
EguqL24MxJMnTzAUgJMByna7CAgAAJwMULaAgAAAnAxQtoCAAACcDFC2gIAAAMDJAGWLgAAAwMkA
ZYuAAADAyQBlCwgIAMDJAGULCAgAwMkAZQsICAAAnAxlC2UmIPQJa81b4aMJtLTvxMRE3nrtp/03
o0K8ePHCfulQn8sO4+fPn3Ya6erqarvfgQMHcp/LpgKvH/qq6KVLl+wXTDUDZ2dnp/00ul8umu5b
21Q2vb29mbYD8IxStlCiAqK/v99OguXT09Njjh49ah2yj/b7559/NqVCSBS8fPkycrsmb9LkX27y
rt+/f5tr167ZH6wfqiOaQ0X3XT/db4kIx8WLF83t27dz2+/du2c6OjpSbwfAyVC2UKIC4s2bN+bM
mTOrohL//vvvqmiD9tP+DrXwq6qqbOtTLcdghVDEQq3LiooK097eHjnBkkPOR2lp/+PHj+ciI2nm
v5DACItKaEIwh0SFu56Ghoa8vATTTcqbZi/VrKKaNyQobuLOk5R2uaH768+4qingFU1w6H9/u/7f
vXt36u0AOBnKFkpUQIja2tqcEdc025pdUcj5ff36NecYampqcseMjIxYJ6rjtE0Taakl6VeIw4cP
2/Tc7J7nz5+PvDjN3Dk0NJRriSp9OeG0FUzXrPPLeUdx/fr13ERP6p5x+QymnyZvp0+fzgkciQdf
wMSdJyntckf3f+/evZECQdvjBEZwOwBOhrKFEhYQFy5csGMMhBya67rQ37GxsZwj9AWAxiL4hl9o
3IFfIfyIg/aNGr/goh6+89f/6hNPW8F0Lp1fjvzUqVO2u8WfityJjOA1h6WfJm/BcSP+8XHnSUq7
3FE3kgSUQyJQ3RLKs2ZnVZ1S1CbtdgCcDGULJSwgNGhS4x5EV1eXmZyctP/rr5bF5cuX7X4OOepg
14Jv+MPOFdbN4AhzGv7+aSvY27dvzeDgoI0Q6Pg7d+6kOr+ffiF5Cx4fRVLa5czi4qKtL4qsODQg
UuvcVN+qU36EIWk7AE6GsoUSFhAy+DLewu/O0F/11bvtfoQgyemFnSvOMYQ5XT+NQirY7OxsXus+
rYAoJG9pBcRWbV2rjvz111/m+/fvsfvNzc3ZOlbodsDJAGULJSQghFrscgBnz57NW6+Bk1qnbgGf
pqYms7S0FFshPnz4kFuW+Ni3b1/k/kov2IXhC46kChYczOfQQEWHRFCaLow0eYtbF3eepLTLNfKg
VzkXFhYS99VYGL0xU+h2wMkAZQslJiA0ZkDbNcgvzXoNerx161Zu0KOW9eaEXyFOnjxpnYu2a9+k
QZSuL1w/vRrooiJpKpje4FAanz9/tsvqT1d6rmtGqG/edc+8evUqchBlmrzFPQBx50lKu9zQ2zrH
jh2zg2XDUN4lCsT8/Lxpa2vLGxuTtB0AJ0PZQokLCL1toe3OATu0HDZoUOgbEnrlTpECRTDcGxuu
Qkh0qAtE2yUmwtIIigBFDPTT4LpPnz5lqmB6PVKiQ90EGoCp9PyohkSFvlGgLgYN2vQdVTD9pLzF
PQBx50lKu9xQVCk4psO/F8p7a2trboyDezsl7XYAnAxlCyUuIAAAcDJA2QICAgBwMkDZAgICAHAy
QNkCAgIAACcDlC0CAgAAJwOULQICAAAnA5QtICAAACcDlC0gIAAAJwOULSAgAABwMpQtlKGASCq8
Qia10iecte/U1FTodn3iure31+zduzf3xUZNJe7z8+dPO72zviqpfTQxlr42CaWHvr7pf3rcR18E
1Zc3Kyoq7Bc6oz57DYCToWwBAWEn4Orr67OTcQWRMNDni0dHR3Ofmn737p3Zv3+/efjwYW4/Tar0
6NGj3MRU2lfOSD8oHTQTZ0dHR2jd0HTqQ0NDubk/bt68WdZzfwBOBihbBMQ6CgjN7eBm3pQoCLY4
NdmUJpEKIhEhYeEImxZb4kMzb0LpIEHg5kwJoqjR8vJy3rq46c4BcDKULWxjAaFW5j///GP/18RR
wW4HzcAYnLQrDO13+/btvAmxoPRw3VRJdUPTmKsuMF034GSAskVAhFJXV2enZhYLCws2ClFIC1Qz
NaoFq/1PnTplpxZ//fo1JVmGRqCrqys30+p///3HzQKcDFC2CIh8JicnV/VxnzhxIm8wpQbTZeHt
27dmcHDQTn0tMaF+dShPI6DxK01NTdwswMkAZYuAyEdOXvsEf1rvaG5uNt+/f191rAbjPXv2LDb9
2dlZG5WA8jQCKmPGQABOBihbBEQeX758sd0X7q0Jh5a13g2mvHHjhn0DI4jeuDhy5EhuWYMlg2kJ
hcGhPIyAXtP1xaLGs+i1XACcDFC2CIgcEgZhb1cIdTu4wZQ/fvyw330YHh62I/QlEp4+fWoFgz/G
QeFupecGXOpbA/fu3TM9PT2UZpkYAZWh6oV7jVODa90AWwCcDFC2W0BARP3CBETUT10TcvJhSCj4
fd8SBX/99ZeNJuzYscO+vqmPTwWR6NAHirSPWq5ySLyVUT5GQF0WEny7du2yZc03PAAnA5TtFhIQ
AAA4GaBsAQEBADgZoGwBAQEAgP2ibAEBAQCAkwHKFgEBAICTAcoWAQEAgJMByhYQEACAkwHKFhAQ
AICTAcoWEBAAADgZyhYQEAAAOBmgbBEQAAA4GaBsKSMKCQBwMkDZAgICAHAyQNkCAgIAACdD2QIC
AgAAJwOULQICAAAnA5TtdiwjCgoAcDBA+UJBAoLCAgCcC1DGUJCAcAXGjx8/fqX+AwQElJiAAMAI
AAC2AxAQgBEAAGwHICAAIwAA2A5AQABGAAAA24GAAMAIAAC2AwEBgBEAAGwHICAAIwAA2A5AQABG
AACwHYCAAIwAAAC2AwEBgBEAAGwHAgIAIwAA2A5AQABGAACwHYCAAIwAAGA7AAEBGAEAwHYAAgIw
AgAA2A4EBABGAACwHQgIAIwAAGA7AAEBGAEAwHYAAgIwAgCA7QAEBGAEAACwHQgIgCQjwI8fP36F
/AABAQBACxMAAQEAgIAAQEAAACAgAAABAQAICABAQAAAAgIAEBAAAAgIAAQEAAACAgABAQCAgAAA
BAQAICAAAAEBAAgIAEBAAAACAgAQEAAAaYQDcx4AICAAABAQAAgIAICNFREAgIAAAEBAACAgAAAQ
EACAgAAABAQAICAAoNxFBAAgIAAAEBAACAgA2EhHym/7/AAQEABAKxwoc0BAAACOBCh7AAQEAA4E
qAMACAgAnAdQBwAQEAA4D6AOACAgAADnAdQBQEAAAM4DqAMACAgAnAdQBwAQEAA4j5JjdnaWgkVA
AAICADbDeYR9uXDnzp3m5cuX63b+YjmyXbt2UbAICEBAAMBmCYggEg8VFRVFFRHr4bxwiNwvQEAA
QAkJCCciFImI2y8YVXj48KGprq42lZWVpqenx/z69StyX8fv37/NuXPnrGBpaGgwb968yW2bn583
p0+fttt0Ldr+7NmzXBph8z0MDAyYqqoqew29vb151/vixQubzo4dO0xTU5OZnp6mDgAgIACgmAIi
zulHbW9paTFfvnwxf/78sY78ypUriWldv37dPHnyxP4/MTFhGhsbc9uam5vN2NiYTU+/oaEhs3fv
3shrGhkZMaOjo3bflZUVMz4+bm7fvp3b7nfNTE5OmgMHDlAHABAQALDZAsKPHiwvL5t9+/YlpiXB
IIefFkUPoq5JAiaYli8SJD6cWKEOACAgAKBEBETQeUd1gfj/+/uE8fbtWxul6O7uNgcPHoy9JqUV
7NrwBYeiDi5ScuPGDeoAAAICAEpBQARZq4DQmApFKB48eGCmpqbM169fY8/pi4U4QaKukra2NtPX
10cdAEBAAEAxBUTSIMqFhYVVznxmZia3/OPHD7N79+5EAVFfXx/ZhaHjl5aWYs/po4GR/v5x6Fq3
m0NFQAACAgDWVUDobQW9+aC/fqTADUD8/PmzfTsi6MyPHz9uvn//bgXBP//8Yzo6OhIFhLon1LUg
Xr16lTeIsq6uLvfWxdzcnDl06FDesbpGDdrUmxzi7t275tatW7lBl1rWNTmUtstTUCAhIAAQEACQ
UUCk+ZCUc7jqJlDUQI44KArk7GtqauxgxatXr9ooRJKA0KuenZ2dNm2NcXj//n1u2+vXr+0gSG2T
89cASP9YvWGhj0n5H5Tq7++3kQutk8hRt4dD3Rc6h/KgNH2BhIAAQEAAwCY4D5wTdQAAAQGA88A5
UQcAEBAAsP7Og3kpqAMACAgAnAdQBwAQEACA8wDqACAgAADnAdQBQEAAAM4DqAMACAgAnAdQBwAQ
EAA4D6AOACAgAHAe2z6f+hS3vlYZ3FefwXZfvnRf0/z58+eq49vb28vyfiIgAAEBADiPNeTzyJEj
uc92++Ih7LPe/nweHz58MCdPnlx1LHUAAAEBsO0cq9Zrjgi1uFtbW3PrBwYGTFVVlamsrDS9vb2r
jtEU29XV1WbPnj3m8ePHduIqterD5tG4du2aTUeTX2lyK02ApZb9vn377FwYPpoYS7NqprkOTZh1
+fJle97a2lozPj6e6CSV3v79+1eJAE3vret7/vy5XX737l1uXhA/325CLwQEAAICYNsLiJ6eHuuM
3cRTIyMjZnR01K5bWVmxjlkTV/nHnD9/3m6Tw5UDv3jxol0OznIpYTE0NJSbIVNpnzt3zm67dOmS
3e4zODhonXya69C+bvZNzQJ69OjRWCcpUaCJtDRJV5IIcJOFdXd359YpGqEJwhAQAAgIAATE/79e
EQGflpYW65R9NDYg6hgtLy0thZ5Ls1+66bZdhEGRC6EuAUUh3Ln0V9EBl3bSdShi4qetmTyj8rm8
vGxnEVU0xF1j1L46h7Zpfz9ffv4QEAAICIBtLyCCKIIQHAuglnvUMXHL/nF++o5jx47ZKIMYGxuz
U3CnvQ4/HSdAovJ54cIF2zWiSEaSCNA+mppc27u6uhAQAAgIAAREmvVhTj+tYAguB518cPvExIRp
aGiw/8vBT01Npb6OpLTDnH7YT0i4qCtGXRT+MWGThCEgABAQAAiIkPVy5GGh+0IEhNIKdmEEnXJd
XZ0dz6DuiyzXcfjw4by05+bmChYQ7u2KK1eu2GUNEtVyTU0NAgIAAQGAgEizXgMb3eBE/bSstycK
ERA69t69e7m0hoeH7dgCHw2M1FsU/gDJNNehLo+bN2/mBlGeOHEitZMMioB///03VFwEB3kiIAAQ
EAAIiJj1/f39NqSvaIHC++4NjawCQrjXOPXTGxifPn3K2764uGjPIxGQ5TrEnTt37KBMveqptzYK
FRDCdae4AZRKL+2xCAgABATAthIQQB0AQEAAAM4DqAOAgAAAnAdQBwAQEAA4D6AOACAgAHAeQB0A
QEAA4DyAOgCAgAAAnAdQBwABAQA4D6AOAAICAHAeQB0AQEAA4DyAOgCAgADAeQB1AAABAcCDh/Og
DlAHAAEBADgPoA4AAgIAcB5AHQBAQADgPIA6AICAAMB5AHUAAAEBgAMByh4AAQEAOBKgzAEBAQAb
4VD4bZ8fAAICAICWOAACAgAAAQEACAgAQEAAAAICABAQAICAAAAEBDcBAAEBAICAAEBAAAAgIAAA
AQEACAgAQEAAAAICABAQAICAAAAEBAAAAgIAAQEAgIAAAAQEACAgAAABAQAICABAQAAAAgIAEBAA
AAgIAAQEAAACAgAQEACAgAAABAQAICAAAAEBAAgIAEBAAAAgIAAQEAAACAgABAQAAAICABAQAICA
AAAEBAAgIAAAAQEACAgAQEAAACAgABAQAAAICABAQAAAAgIAEBAAgIAAAAQEACAgAAABAQCAgABA
QAAAFFE4BH8AgIAAAEBAACAgAADWV0QAAAICAAABAYCAAABAQAAAAgIAEBAAgIAAgHIXEQCAgAAA
QEAAICAAoNScLb/S/wH1dTvVbWo8AC11oKy4B5C5XClpAIwxUGbkHTKXL6UNgDEGyo48Q+ZypsQB
MMhA2ZFnQEAAYJCBsiPPgIAA4EEFyo48AwICADDIlB15BgQEAGCQgbKjviIgAACDDJQdeQYEBMAW
NMjBL8Tt3LnT7N6921y6dMn8/PkTp0K+qa+UGwICgAc13XoZ4r6+PnP58mUMMvmmvlJuCAgAHtT0
6//8+WMqKyvz1g0MDJiqqiq7vre3N2/b79+/zblz50xFRYVpaGgwb968ydt+7do1e5y2Hz9+3Hz5
8iXvGt6+fWv27t1rWltbc+eXQ1Drsra21oyPj+dd64sXL2zrc8eOHaapqclMT08jIKiv1FcEBABs
tkEWvkEeGRkxo6Oj1lCurKxYA3n79u3c9uvXr5snT57Y/ycmJkxjY2Nu2927d83Q0JA9Vj+lJePt
X0NPT4/d9vXrV7tucHDQ3Lp1y677/v27OXr0aN61yhi/fPnS/j85OWkOHDiAgKC+Ul8REACwmQb5
8+fP1iDKSDpaWlqscfTxjaAMcHC74+DBg7bF57f+qqur867Bb+EJtez8Y96/f593rWr9OQewXcuO
+kp9RUAAwKYa5OBPIViFcNVy81tQwf0UjvW3R+HvF7Z/2LUF05Ox9/dTK07LchQ3btxAQFBfqa8I
CADYrBbdt2/fTHt7u5mZmUllVOMMaNK2PMORwiCH7ad+aIWf29ra7CA6BAT1lfqKgACATTDIQq24
06dPm+fPn+et18CvpaWlyPTr6+sjQ8I6NhgS3rVrV+y1HT58OO+Yubm5yDzIgWxlJ4uAoL4iIACg
5A2ya9mpv3hhYSG3TgPL3CAx/bSs0ekODUpTmFa8evVq1aC0e/fu5Y4dHh62BjzuGsbGxszNmzdz
g9JOnDiRt5/S18h2ocFpcS1KBAT1lfqKgACADTDIzqgeO3Ysb11/f799TU2tMbX63Ah08evXL9PZ
2WkNowahaRCZj3stTj+NaP/06VPiNdy5c8cOXtOreBoJ7++ncLDOo1C1zumMMwKC+kp9RUAAAE4I
EBCAgAAADDJQduQZEBAAGGSg7MgzICAAMMhA2ZFnQEAAAAaZsiPPgIAAAAwyZUeeAQEBABhkoOzI
M3UbAQGAQQbKLlue4vJFfUVAAABOCCi7SAER/FFfERAAgBMqm3xrQqaw/cbHx01DQ4P9cqC+MHjl
yhXz8+dPu02fLNaXDjVNs750qFkWp6am8o7Xp5T1iWUdr/2uXr2aO76QPEQ53a36K5dnYyOOL6SO
Li8vm97eXlv3/Dqor3AK/S2le4+AAEBAlE2+P3z4YE6ePBlqNJ89exZqWLu6uux2GeKw7e/evcuJ
h7DtHR0dlF2JRSBKWUCspY7+9ddfodv1aW6hz2kjIACgYCMlI6LWib7Rr1kIp6enc9s0u6CMTUVF
hW3lvHnzJi89fd9frZrW1tbc+oGBATsXgOYQUOsnSNx2pTk6Omrq6upycwZo4qG0xysqcPnyZTv/
QW1trW2dJfWzHzp0KNRousmQdD7f2OpeCJ1fy24OBU3T7BtvTdmsfd0skRIW2l7IJEqMgUhXh3Tv
NSeGX7fVck9Tl+PO669LU8dKpY7qGdKye6b//fffvO0PHjywy5r3oxTsEgICoMwEhO+kNTuhQu4O
zVj45MmTnIP0ZyxUej09PdYgukmKNIGQBIDWaZplGcfbt2/njknarjQ16dGXL1/scnDWwqTjBwcH
czMwakbEo0ePxhpnRQN+/PgRapw1c6OMvM4j9Ff77N+/3y6r20LLr1+/zhMICiNHCTVt7+7uRkCs
Ic9xdUD1UM5W2xSeV11WCz5NXU4rIJLqWCnVUU3e5ddR/dWy1gsJKi1rplHV55qaGjujKAICAFIZ
ZEUQnGENIiMrQxeVnnP0Do0DCO7vC5Kk7WFp+teddLwiIWppOhQdSON804Rt1UrTPu5eqa85LPQb
FmHQNTpDvbS0hIBYQ56T6oAcuJy0nLbKKG1dTisgkupYKdXR2dlZG1X062dzc3NOVEmAhNVhX/Ag
IAAg0vgo6qBtMnw3btxYFZ3Ikp72DxojhVHTbk8y3mnS95EhL4ZxVhha2+WYHGrtyWAr4qDW2/nz
523IWv8H0b6uv9p1cSAgCo+YxdUB58RVLouLi5nrcpo6GFfHSqmOKuKgqIJ/LVp23TynTp2y98kN
/lXkRPuoCxEBAQCpnJDGMiisq377vr6+ggVE0JBn3Z5kvJOOD7vetRhnhY51T7Ttzp07sWkoZK7r
27dvn11WV4zCy0rDP0+YwEBApM9zUh1wjlERh40QEKVcRxXxCuvC8CMiYecpZJwOAgJgmwoIx8zM
TN5+MkBpwr4OhUvjQvRJ25OMd9Lxhw8fzgsPz83NFWycZZgV7tV6RQ/C8qLBaBqYpnuk8SDa98KF
C3a7GznvwuhuwJpagAiIwvOcVAeGh4dtS1r32+/CSFuXg+ddWFjIW5dUx0qpjrpxOi7ioMGUvojV
PVEddse6CITSREAAQKJBVktNA/xEcNCiBp6pi0PICEUNPHPcvXs3N0BMPy2rnzXt9iQBkXT82NiY
HQTmBqi5UeqFGOeo1zTdfi5k7P8UcZBDEG7Ee/Cna0ZAFJ7nuDqgQZRHjhzJc+YfP37MVJf9QcWf
P3+2kSR/e1IdK6U6qm61sG1O5OrtjbDtT58+RUAAQLJBVveFRmW71yadmBAKy3d2dtr12se9shiX
nj6uJEeqVo6Mr3tDI832JAGRJn2FcdWvq9foNKCuUOMc7DsOGmfdG72Op+vQT45AERwfdQvplUE3
gFLXs17Ro+0UMYuqA6qr/muc+l/bs9RlJ6L1PKjM3NszWepYqdRRRTo0TkfdasqP9teyHwGR2NHr
pNouUSWBs1nljIAAKEODDJQdeYbNLmdKHACDDJQdeQYEBAAGGSg78gwICAAeVKDsyDMgIAAAg0zZ
kWdAQAAABhkoO+orAgIAMMhA2ZFnQEAAYJCBsiPPgIAAwCADZUeeAQEBABhkyo48AwICADDIgIAA
BAQAYJCBsiPPgIAAwCADZUeeAQEBgEEGyo48AwICADDIlB15BgQEAGCQKTvyDAgIAMAoA2VG3qnb
BgEBgFEGyop7AIWXKyUNUCYPL7/S/wH1dTvVbWo8ANBSBYDszzC3AAAQEACAgAAABAQAICAAAAEB
AAgIAAAEBAACAgAAAQGAgAAAQEAAAAICABAQAICAAAAEBAAgIAAAAQEACAgAAAQEAAICAAABAQAI
CABAQAAAAgIAEBAAgIAAAAQEACAgAAAQEAAICAAABAQAICAAAAEBAAgIAEBAAAACAgAQEACAgAAA
QEAAICAAABAQAAgIAAAEBAAgIAAAAQEACAgAQEAAAAICAAABAYCAAABAQAAgIAAAEBAAgIAAAAQE
ACAgAAABAQAICABAQAAAAgIAAAEBgIAAAEBAAAACAgAQEACAgAAABAQAICAAAAEBAAgIAAAEBAAC
AgAAAQEACAgAQEAAAAICABAQAICAAAAEBJR1+fLbWj8EBAAgIICyhTWXK6UMADgZoFwhc/lS0gCA
owHKFDKXM6UNADgboEwBAQEAOBugTAEBAQA4G6BMAQEBAICzoUwBAQEAgLMByhQBAQCAs4FyL9PZ
2dmSSme900RAAADOBrZkmWb5umGatJOO27VrV1HyU6x04tJMew9K6XlBQAAAAgI2TEAUM+2k9IpV
t9ajjhaaJgICAAABgYBIuU+UaIhLLyrCMTAwYKqqqkxlZaXp7e3Nre/q6jKvXr3KLb948cK0t7en
ipTMz8+b06dPm4qKCrNz507T0NBgnj17lnctb9++NXv37jWtra2hafpp//7925w7d86mp7TevHkT
meeo/Lg86Hp27NhhmpqazPT0NAICABAQgIDIGoEYGRkxo6Oj5s+fP2ZlZcWMj4+b27dv221fv341
hw4dstt+/fplDhw4YD58+JDqPM3NzWZsbMweq9/Q0JAVC/519PT02G06T1ia/vL169fNkydP7P8T
ExOmsbExdL+4/AiJh5cvX9r/JycnbZ4QEACAgICyFBBJ4x/WU0C0tLRYZ+vjO1U55MHBQeuEr1y5
sqY6qla/f/yXL19ir81flmAIXmfYfkn5kYhxQmQ9y5knGAAQELClIxBqkQfFi+/onVOurq42i4uL
ma5bXRSKHHR3d5uDBw8mXmecgNB1pslTUn4UddA65enGjRsICABAQAACIs+BRUQ0gmkFxUIYp06d
shGALALi4cOH9pgHDx6Yqakp202xEQIiTX4kbNQN0tbWZvr6+hAQAICAgO0hIBYWFooWgdBAwqWl
pcj9h4eH7ZgCCYEsXRi7d+/OSzfumtMIiPr6+lRdGEn58ZmZmSn6s4aAAAAEBJSMgPAH/n3+/Nm+
3VCogNBbDBp7oLcaxN27d82tW7dygx21fPz4cbtNUYMjR47kOeePHz+GphOkrq4u99bF3NycHYyZ
dJ3BNIODKNX9IPRmSNQgyrj8CB2nNzGE7mlcZAMBAQAICChrAeEcncLzaonLARYqIDQYUh9s8j/a
1N/fbyMGWidx4t6K6OzszHuNU/9re1Q6Pq9fv7aDF3XdctoauJh0ncE0/X30FoiuR+lpPMX79+8j
04rKj1D3hY7XvVRaTkwgIAAAAQGUKWx6OVPaAICzAcoUEBAAgLMByhQQEACAswHKFBAQAAA4G8oU
EBAAADgboEwREAAAOBugTAEBAQA4G6BMAQEBADgboEy3OrOzswgIAACcDWVaiufa7OPj0gt++bLU
nhUEBAAgIAABUYJ5jZtwCwEBADgbBMS2KtOBgQFTVVVlKisrTW9vb259V1dX3lwUmrehvb3d/q8J
p86dO2cnoGpoaDBv3rwJPVfSrJeacOry5ct27oja2lozPj6+6pio60t7fBT79+/PTRHuZut89+6d
Xf727ZvdnueUQ6Yo19979+7Zybvc/BZu4jEEBADgbGDLlunIyIidLluOeGVlxTpgTSolNAmUZrHU
Nk0mpcmpPnz4YLdpdkpNUCUmJiYiZ6dMEhCDg4O52Su/f/9ujh49mrc97vrSHB/HX3/9ZZ4+fWr/
f/z4se2e0PncsgRSUn60fOrUKTuLp1iPGTYREACAgICSK9OWlhbrfH0kFHwHLictp33lypXcegmG
4HGFCIjW1ta8Kbk1y6W/Pen6ko6P4+HDh+bSpUv2/7///tt0d3fbnzh//rwVK2kEhBMPpfD8ICAA
AAEBG1Kmai0HQ/MKxQdFRnV1dS7c745Lc64kARFMR2IhuD3u+pKOj0PRlObmZvt/U1OTmZmZMfv2
7bPL6pZRt0YaAVFKzw8CAgAQELAhZRoUC2EoRK+Iw0YIiOD2pOtLOj6JPXv22K4PJxw0lmFubi63
jIAAAEBAUKYhqOW9tLQUedzw8LAdg/DgwYO8Loz6+vqCujDcYEXH4cOH87og5Lz97UnXl3R8Eh0d
HebChQu5rgvXjeGWERAAAAgIyjSEu3fv5gYh6qfl48eP220aRHnkyJE8Z/7x40f7vwZRTk5O2v/1
pkbUIEr/rYTPnz+b06dP520fGxszN2/ezA2CPHHiRN72uOtLc3wSeoNC3TMSSuL+/fv2zRKJprD8
aJvGPDjRgoAAAEBAbNsy7e/vt69B6i0EOXgJB9HZ2Zn3Gqf+13ahtzK0XQLh4MGDdvBi2LncWwnq
ilDUQq+CBq/lzp071onrVU0N2gxuj7q+tMfH5f3ff//Ne33TDcJ0Qil4vAaT6jrcB6UQEAAACAjK
dIuiNyy2WznzBAMAzgYo0zWi7hYEBAAAzgYoU0BAAADOBihTQEAAAM4GKFNAQAAAzgYoU0BAAADg
bChTQEAAAOBsgDIFBAQA4GyAMgUEBADgbIAy3Tw0Hbdm1dSXMPWlSs3l8fPnTwQEAADOBijTcJ49
e7ZqGnD9urq6EBAAADgbWGuZav3bt2/N3r17TWtra279wMCAnVuisrLS9Pb25h0zPz9v56TQxFJq
3auVL4ft0HwXbv4LTcA1PT2dd/y1a9dsujpeE2Npcir/ejSRlabV1vH+ZFxp0na4SbWUD3eclnVO
BAQAAAICiiAgenp67GyWbpIqTUglJ651KysrtitAk0g5mpub7SyYbobMoaEhK0AcvtPXjJ0HDhzI
bdNsmtrfHatznTt3Lu96JE6cqHCTcaVJ20fCRBNw6fqF/irt/fv3IyAAABAQUAwB4UcAREtLi3Xu
PlGO2qGIgENi4smTJ6H7aeZONxW20P8anxB3Pf61x6Udh6IeSqeQYxEQAAAICMo0xXq18oNjB3yB
INTtoUmquru7rSjw01FkQMsSIjdu3IgUGv754q4nbdpRqAtGxwwODm6bcuYJBgAEBGy4gAhz8j4P
Hz40jY2N5sGDB2Zqasp2fQTTkcCYmJgwbW1tpq+vL1QshF1DkoCISzvIjx8/7D46/s6dO9uqnHmC
AQABARsuIDQ4cWlpKTItjS3wty8sLESmPzMzk7dNaQe7MHbt2pVJQESlHRQPGquh7f4ATwQEAAAC
AtZJQGig461bt3IDHbWsQYkOvSHhnPLc3Jw5dOhQXjqKTuitBxEcBKm07t27l0t7eHjY1NfXpxYQ
cWn7XL16NfQ1zq1etxEQAICAgE0TEKK/v99GGhQd0FsR7g0N8fr1azuoUs5bDl0DE/101MWgcRHu
NUzn8B3uNU799AbGp0+fUguIpLQdNTU1CAgAAAQEUKaAgAAAnA1QpoCAAACcDVCmgIAAAMDZUKaA
gAAAwNkAZYqAAADA2QBlCggIAMDZAGUKCAgAwNkAZQoICADA2QBlCggIAACcDWUKCAgAAJwNUKaA
gAAAnA1QpoCAAACcDVCmgIAAAJwNUKaAgAAAwNlQpoCAAADA2QBlSjkjIAAAZwOUKSAgAABnA5Qp
ICAAAGcDlCkgIAAAcDbbsky1PuqXNX3/mDRpvHnzxhw/frzoeV2vdBEQAAAJTqBQJwIIiCwCYr3q
2HauuwgIAEBAwIYKiKwOOUkwJKUbV9fGxsZMfX292blzp2lqajITExO5bXNzc2bHjh3myJEjuXWt
ra12nbZt9zqMgACAkhARgIDYaAHx4sWL0G3qlnD09fXZdS9fvjTj4+P2/4GBAUQwAgIAEBCw0QIi
zumuh4CI2ufYsWM5cSCmp6ftcmdnZ26fX79+mf3799voRF1dnTl48KD58+dPpnMjIAAAEBBQBgIi
LP2wdHft2hV6Pbt3787bT90abtv79+8zR1UQEAAACAgogoDIEin4/fv3ugkIjXsIExAa4+Bz9+7d
3LaRkREEBAICAErZ2cD2FBDOqatbQV0Fly9fLmoXhroklpeX7ToNiNQ6jYWIYnFx0ezZs8fU1NTY
yIT+17q4dBEQAAAICNhgAXH06NHEro5CBITGL7j9urq67LrHjx+HnqetrS133MWLF+26R48emcHB
Qfv/pUuXYtNFQABAyT2s/Mrnh4AoTEB8+PAh96rkgQMHrOMuhoB49uyZjSIowuG/ljk6OmoaGxvt
+aqqqmzE48ePH3bbf//9Z9M9fPhwbv+Wlha7Ttvi0kVAAACtdKDMyDsgIAAwxkDZkW9AQABgiIEy
JM+AgAAADDFlSJ4BAQEAGGLKEAEBCAgAwBADZUieAQEBgCEGypA8AwICAEMMlCF5BgQEAJSMIZ6d
nS2pdNY7TZwpeQYEBMCWNMTF+AJi8Et+cWjWwmJQrHTi0kx7DzbKySEg1s6bN2/M8ePHQ5+BLNeE
sEFAACAgimAIswiIYhne9TDghaaJgCifPBfD+SMgEBAAGOKUBjpsnyjREJdeVIRjYGDAzh1QWVlp
ent7c+s1odCrV69yy5rpsL29PVWkZH5+3pw+fdpUVFTYuQUaGhrsXAP+tbx9+9bs3bs3N5Ni2LTN
Dk0Ffe7cOZue0lJLNirPUflxedD1aL6EpqYmMz09jYAoIM8LCws2kuDKV2UYLBO/jDW3RFSULawe
aV6L2tpaG5W6cOGCWVlZiRUQY2Njpr6+3l6LynViYiJv+9zcnJ3cS9t1zbr2z58/Y5gQEAAIiEIj
ECMjI9ZYa7plGenx8XFz+/Ztu+3r16/m0KFDdpumONaESJogKc15mpubrVHXsfoNDQ1ZR+JfR09P
j92m84Sl6S9fv37dPHnyxP4v56BJk8L2i8uPkAPR9NJicnLS5gkBkT3PYaJPwi5KrJ49eza1gFA5
B/e7ceNGpICQKAxL2xc0Bw8eXLVddRsQEABlLSCSxj+sp4DQjIRytj6+U5VD1tTHcsJXrlxZkzNV
q98//suXL7HX5i9LMASvM2y/pPxIxDghUqwy3I71Nhht0n7+GBZXj10ESBGLqOhBcJ1mzNSyhKIE
q/73yzC4/7Fjx+yyE4aKKmm5s7Mzr+5pHVEHBAQAEYgiCQi1yIPixXf0zilXV1ebxcXFTNet8LUi
B93d3bkWYNo8BZd1nWnylJQfRR20TnnyW7UIiOx5Vgu/r68vNy122LTcQYedRkC4Moy7Jn+7hEuY
CN+9e3duH3WDuLqg7hSVvZvqGxAQAAgI3xBERDSCaQXFQhinTp2yEYAsAuLhw4f2mAcPHpipqSnb
TbERAiJNfiRs1Lpta2uzDhABkT3Pw8PDdlt/f38uShAmIJKcf5yAiIs4JYnGoHBUd5ZEg+qyxlZo
+4kTJzBMCAiA7SUgFA4uVgRCA86WlpYi95ej0JgCCYEsXRhq/fnpxl1zGgGhAXJpujCS8uMzMzNT
8Ouy273eqny1TeXqojpZBITG1CwvL4fu67ownj9/br8Nov81KDYqbTceQ2Mh0iAhrP3jRCkCAgC2
hIDwB/4pJKy3GwoVEBqBrrEHeqtB3L1719y6dSs32FHL7j19RQ0U7vWd88ePH0PTCVJXV5d760Ij
4DVgLek6g2kGB1HKUQm9GRI1iDIuP0LHOUeje5rFiSAg/h/79+/Pa+3rjRf9deItSkCoXrhtessn
bN+wQZQacBslIB4/fhwagVCEKShK/J9ft7FPCAiALSkgnKNTSFYtcTfqvBABocGQ6jP2B7wpDK0W
pdZJnLi3IjQIzX+NU/9re1Q6Pq9fv7YD33TdctrOKcRdZzBNfx+1WHU9Sk/jKd6/fx+ZVlR+hLov
dLzupdJK22pFQOSj8Q+6j7qHerX306dPdt+rV6/GCgiJypqaGnucc+Bh+2rwrga8utc4XbQian9F
yVTPVK6KVly+fDlvjIPqQEdHR+61U4mL4CBe7BMCAqCsDDFQhuQZEBAAgCGmDMkzICAAAEMMCAhA
QAAAhhgoQ/IMCAgADDFQhuQZEBAAGGKgDMkzICAAAENMGZJnQEAAAIaYMiTPgIAAAAwxUIbkGRAQ
ABjissy7vgSpLwNqRkfKkDxHXYN/HfoKpv958rB9AAEBgCHe4nn35/mgDMlzIYICEBAA29IQz8/P
2/ka3Df6GxoacpNQ+S10feNfk1lNT0+n2iYGBgbsvACa6Ki3tze05V/sdDWBleYh0FwUmjZ5fHw8
dh6QsCnHr127ZtPWPVFL05+zQPtpPgvNk6BZGBEQm5NnzcKpsnH1VmWhyIDQHBk6TtN8i6GhIbt8
584du6wJ2bSsupWUVlAwhE2aFSYq3LLmYNEz5dLVDKw+mm22urraTg6merVdxQkCAqAMDXFzc7MZ
GxvLzR4pYyvnGNZC12yUmqAqzTZNRqQJhpTmysqKdeSarGq90x0cHMzNhvn9+3dz9OjRWIMc3KbZ
M3UP3P3Q+c6dO5e3v2Zm1DZ/kiwExMbm2U2h7f/kqIVmTtXyvXv37LImQdOy/vqCQpOeJaW1VgER
/PmiMziL5759+xAQmGqA8jHEYajl75CYUCsqjLhtGlMgJ+vjC4H1SlcG2p/iW7NmZhEQar36x+t/
tRD9/TdrFkUEhImMomk/N4vqu3fv7PKpU6fsshyztjlhfObMmVwkKSmtOHEQFs0KLusaJHQV1Qum
66b4dlE0CVMEBACUlSGWIVWrrbu7Oxf+dSgCoGU57hs3buQdF7dNUYRg68sXJuuVrrb7SGxkERB+
WmFpbqZxR0Dko26Gvr4+W0+CjtdN2f3t27dc9MGJP61X91batNYiIILdX/4+ri67fdSVgoAAgLIx
xA8fPjSNjY3mwYMHZmpqyoblg/tKYExMTJi2tjZrZNNsC3PEYcKl2OkGBUSSEwpuSzoeAVEaedbY
AdcNobEOQcd78eJFu3zhwoVctEF///77b/tX42TSprUWARG3jxMQEg4ICAQEQNkZYg02XFpayi07
IxaGBoCl3aYBan66cRQzXYWF/S6Iubm5TAJC6Qe7MILhbAREcfOUpXz8euucr4tY+ftqDI2WNdjW
dV0o6qBlrdcxadOKWv7165dZXl4uWEBo/JHrwlCkzIkbBAQAlIWAqKury711IWd76NChvH0VndBb
Ec4o+y30uG0ajOgGM+qnZf/d+fVKVwNCb968mRtEeeLEicyDKDX4zqWv1ml9fT0CYp0FRNQbMVF5
1lsL/v56a0Z/nbhU2bl1bvBkV1dXbl9/HE1SWsFr0jPj1inNQgXE/fv3886reo+AAICyERCvX7+2
gxDlpGXANHjR31ehX42LUNeB9nGOPWmbUEhYrTu14PWqqP/WwnqlK/S6ngY+qrWptyiytnDda5z6
6Q2MT58+lZSAiHK6W/UXhsYsqI6ofrS3t9sy0r5Xr17N7eMEg97MEe7tC+f006YVvA4JbjfG4siR
IwULCKGuQ9VVPXvu9dI03X8ICACg9QpEIAqIQGwFJBSUP/dtCI350bL/1g8CAgBwPkAZxgiI7Vhv
3eukwZ9e50RAAADOByhD8hyKxuicP38+1x2nyIPEw8+fPxEQAIAhBsqQPAMCAgBDDJQheQYEBACG
GChD8gwICADAEFOG5BkQEACAIQYEBPUWAQEAGOI1MDs7SxkiIAABAQDlYogL/ahPluOi9vX/9+ej
yIpmZDx79qxNo6Kiwn7aWK/Q4UzJ83ZEX970P/8eh77MuRFlgIAA2OICYiPOHbXvWq5D82E8fvw4
N7+F/j958iTOlDxvW1uQdF81K6mekY2amwMBAVCmhnhgYMDOG6G5HzQzYNpIgo7TR3D27NmTm2cg
6rgvX77YeSUUAVCr5v3796kjEMEv9WkWwyArKytm3759oR/hCZuiO2wdzrR88qyZM9WKVn1SWba2
ttqWtUMTwx09etRu0z7a9/Pnz6m3C03MponUtI9madWnpn3Weg5XnzV5m54/Teolx33lyhV7jCbt
+vfffzNdk0tTc9o0NDTk7o37XHbauUa03k2sh4AAQECErtdkU6Ojo7ZlLic8Pj5ubt++nejcdUxf
X19u1ktNKhQnBDTNtroStP/Tp0/tF/jSCojg/4ooTE9P5+VD13Px4sXYCIRDxvXYsWMIiDLOs5xi
0BHKYTo0OVZwuxxi2u2awC3M2foiZa3nCEtfoiC4nOWaouYW0f3KIiA6OjrMjx8/EBAAEG2IW1pa
8qY2FpqdM8mJO0HgUEQhzvn7EQedT+ctVECo1dXW1rbKofz333+heVSrTlESZwz1v9YhILZGnufn
5+1+/jgZN1FVMKqQdrsEprZrOnkhwepPDV6Mc7j6qKiCy4N+Dx8+zM3M6UfK0lyTS+PUqVO2QaCZ
Q4P3JosoQEAAQKQRkIEKtkj86YTTDmqUKEjj/P3zFioghMK7TgRInLgWVhia8vvu3bu5MRCa7lst
LAREeedZLW9FwSRGg47uwoULubqs6NiNGzdsizrtdtXvsNa6uuyKdQ6XphPwUctZrsmtU5dhlAhA
QABAUQyxLxaSjvP/D44hyCoggi2irALi5s2b5tKlS/Z/ja24f/9+ZB50Lj/Kov/VJ42AKN88Dw8P
2239/f1WSAYdnVrfcthqidfW1tpt6spKuz1MWAfF9VrPkeTYg8tprinM4SMgAGBdDLH6WJeWljIL
CPXl+q9Cqvsgzvn7XQa/f/+2Ax7XIiB0bokAdaNoANqvX78i8xAUCxIQGjCKgCjfPKvVrW0aTDk5
ORnr6BYXF1d1ByRtd2MsNO4gDYWcI6uASHNNWQSEnpnl5WUEBAAUZogV2r9161YuvK9l/x3xtIMo
dUyc89crYTKi2l/nyzqIUiJAYVmJD4ciD2fOnLFTIMeh7Q8ePLAtQp1/cHDQXL58GQFRxnnWGwt+
K1yCUH+dGNYYnWBLXd0IjqTtGnQb1tr3x96s9RxZBUSaa0ojINT959Z1dXUhIACgcOejMLBadAr1
a7zA169fU0UB1I2g1r/Cs3qbI65bQtu1r/aRmAj20Sb9rzdDdKx/DvWBa5+kr1SqpSUR4Y6XeIiL
WCAgSj/PKnu95aAWvV4L/vTpk9336tWrdrvqsMa5uNc85WT9Ope03YnkxsZG20Wguqt6449hWOs5
sgqINNeURkBoYGVNTY29Jl/QICAAYFOcjxyy3y2xEchAqzVFGZJn2BrlTGkDbANDXF1dbV+ndN+P
uHbtmu3S2Ch0XkVONEiNMiTPgIAAgDIxxFNTU3ZQl7oE9F0FhY4lJDYKhYXVFVKOXRE4U/IMCAgA
DDFQhuQZEBAAGGKgDMkzICAAAENMGZJnQEAAAIaYMiTPgIAAAAwxUIbkGRAQABhioAzJMyAgADDE
QBmSZ0BAAPCAAmVIngEBAQAYYsqQPAMCAgAwxEAZkmcEBABgiIEyJM+AgADAEANlSJ4BAQGAIQbK
kDwDAgIAMMaUHXmHci9fShoAYwyUGfcAMpcrpQxQBg8tv/L5AfV2u9RtajsA0EoFgOzPMLcAABAQ
AICAAAAEBAAgIAAAAQEACAgAAAQEAAICAAABAYCAAABAQAAAAgIAEBAAgIAAAAQEACAgAAABAQAI
CAAABAQAAgIAAAEBAAgIAEBAAAACAgAQEACAgAAABAQAICAAABAQAAgIAAAEBAAgIAAAAQEACAgA
QEAAAAICABAQAICAAABAQAAgIAAAEBAACAgAAAQEACAgAAABAQAICABAQAAAAgIAAAEBgIAAAEBA
ACAgAAAQEACAgAAABAQAICAAAAEBAAgIAEBAAAACAgAAAQGAgAAAWAfhEPwBAAICAAABAYCAAABY
XxEBAAgIAAAEBAACAgAAAQEACAgAQEAAAAICAMpdRAAAAgIAAAEBgIDY2kaLHz9+/Pjx47e2bsT/
bTfxAAAAAGv3jf/jBgEAACAiEBCIBwAAgHX3lQgIAAAAQEAgIAAAABAQCAgAAAAEBAICAAAAAYGA
AAAAQEBwUwAAABAQCIiEm7Iek/kUK81SSefNmzfm+PHj63JvmEyptPj161fmL9VlqR9Zy5v6AYCA
QECUcTrFvEc4hNLmxYsXmQXEepYp9QUAAVE2AsItP3nyxDQ0NJidO3ea1tZWMzMzk3fc6Oioqa2t
Nbt27TIXLlwwKysrmVrZYeuGh4fN3r177U//h+0zNjZm6uvr7XU1NTWZiYmJVXlKk47P3NycOXr0
qE2zoqLCtiY/f/6cd51BR1KsPBWSx7jrhbXx4MEDWx7Xrl3L5OCj6sfbt29t2R85ciS0vBcWFmz5
qRzds6aIRlT9oOwBEBAlLyCCPxk2h8RFcPuNGzfWJCAePXqU2PKLah36BjdNOkEOHjy4at9Dhw6t
WUCkuZZC8hh3vbA2zp07Z++nBJzEcU1Njbl582bBAsL9zp49G1reeq6C+0q4R9UPyh4AAVHyAuLU
qVM2qvDs2TO7LGPqOHz4sF2nlvGHDx/s/wcOHFiTgGhpabHLV65cscv6G9zn2LFjdvnly5d2eXp6
2i53dnZmSifIjh077PaollzaaEMheSokj0nXC4WjFn2YKLh9+3aiiAhb19vbm4s0RO3rmJ+fX/Ws
Bfen7AEQECUvIL58+RK5j8KnWfqE0zhbZxi/fv1ql2Ugg/vIsIYZ9927d2dKJ4i6YLRdxyrUrGjK
jx8/1iwg0lxLIXlMul4oHAnn6upqMzU1ZZfVVad7XVdXV5CACDr6sH0VXerr68sJzrj6QdkDICBK
XkDE7eMExJ8/fwpK8/fv35GOc2lpKdLZuvMGfzKmWdIJokiLDLGch8Z1aN8TJ05kuieF5qmQPCZd
LxT/2VG5FCIgkvZ142L6+/tz0by4+kHZAyAgylpAuC6M58+fm9nZWft/VVVVolNUWF6i4/Lly5Fp
qoUlLl26FNlfrHECUaRJJ47FxcVVDsMdr1f8lpeXi5qnQvKYdL1QOBr7oMGJ6rrzIxDNzc2JAsKv
H2kFhCJLWlYXx+TkZKbXfCl7AARE2QmIsEGUPT09kftr1HjSYMKnT58m7vP48ePQ7W1tbZnSiRId
/s+NmhcKX7v1XV1dRc1TIXlMul4onIGBgdD7r7KMIqx+pBUQ+/fvzztPZWVlXtQqSpRS9gAIiLIU
EGJkZMS+nuZe43Qtr7D9FZpVy1pheA229N9O8NErdIpkaOT7vXv3QvdRi7CxsdGmpX3V8g/2AadJ
x0djFDo6OnKv0slZ+2NA1BpVWtrmjHWx8lRIHpOuF9bGrVu3bPeA7r/KQa/VxhFWP9IKCI1/0JsV
Ora9vd18+vTJbr969Wro/pQ9AAKi5G8KAAAAAgIBgYAAAABAQCAgAAAAEBAICAAAAAQEAgIAAAAB
gYAAAADAVyIgAAAAAAGBgAAAAEBAICAAAAAQEAgIAAAABAQCAgAAAF+JgAAAAAAEBAICAAAAAYGA
AAAAQEAgIAAAABAQCAgAAAAEBDcFAAAAAYGAQEAAAAAgIBAQG8Ps7Cw3gXsCAAgIBETcTdH68fHx
DRMcpSBkXrx4YXbu3GlaWlpCt+/atauo+Sg0z6Uk+tLcEwAABMQ2ExCtra3m169f20ZASDy8fPly
w65xKwgIIlgAgIBAQKxaf//+fXPjxo3I/cOODW5/8OCBqa6uNnv27DGPHz82d+/eNbt3717lrLXv
ly9fzLlz50xFRYVpb28379+/z0t7YGDAVFVVmcrKStPb27vqvG/fvjV79+61wieKa9eu2eN1juPH
j9tzuuP9X1i+gtvDzukfOz8/b06fPm3Ppfw2NDSYZ8+ehd4rF/3YsWOHaWpqMtPT07FlFnavPn36
ZJqbm1ftv7KyYvbt22d+/vyZ6Z4klXHYPfn9+3fuupTfN2/eZDpX2vqSpj4AACAgNklAiEOHDkU6
lDQC4vz589aBPX/+3DqCixcv2mU5AzkFf9/Dhw+bb9++mT9//pinT5/aYx0jIyNmdHTUbtPx6l65
fft23vE9PT12+9evX0PzJGc0NDRk99FPacrZpa0gwe1h5/T3kTMfGxvLnU/nltgIS893kJOTk+bA
gQOx1xF1r06cOLFKfOi+6b4X657E1YHr16+bJ0+e2P8nJiZMY2NjpnOlrS9J9QEAAAGxyQLi9evX
pqurq2ABERQfS0tLkfv6EQc5Bn8sgv7XOh/fyQbPFcbBgwdtC9mh/9XaXYuACJ4zKQ1FGML2lbBw
jjdNmUXdKznttra2vP0VHfnvv/+Kdk/i6oAEQ7CcspwrbX1Jqg8AAAiITRYQQgJCQqIQAZHkgOPS
8luc+j8YMo9yxmmcd9g5ChEQSfuoi0Ot8u7ubutAo/KsqIOW5RiD3UZpyszPR11dnfnw4YP9X0Ij
rkunkHsSV27+sWs9V9xyUn0AAEBAlICA+Pz5s+3K2GgB4Y/wT3IOaQo3zLklXcNaBMTDhw9ti1z9
+lNTU7abI+58EhsugtDX15cpr/69unnzprl06ZL9X10EGstSzHtSqIDIeq64ZcQCACAgykBACLWK
5YjiDP7CwsKaBIRrNQuFtzXwz6GBhX44u5DCVRrBELrveIstINSH719z0v1xzMzMxF5L0r36/v27
HaSoMRIaZBh8k2Yt9yQpD/X19ZFdGFnPFbecVB8AABAQJSIg5IQUXo8a+Kcohd44WIuAOHnypFlc
XLQO6NatW3mDKDUAT+vcADwtaxR/lsLVMffu3culMTw8bB1e2jTklNVH75xgkoBQV4J762Jubs5G
caLujyIVehNDBAcMhp0j7l65yMOZM2fsIM+13JOkMg7eE3XXqDtGvHr1atUgyiz3P245qT4AACAg
SkRACI1099c7R6dwshyBHOBaBIRG1qvFrFapHGRwgGJ/f79t1Wu7HJn/tkXawnWvEeonJ6tXH9Om
oVH+OrdrNScJCI0b0cA+3SM5Ug2SjLo/6r7QGAndS+3vxERU2STdK70+qf3SfCky7p4klXHwnkho
dnZ22mOUn+CruFnuf9JyMeoDAAACYoNuCpQHcqaKgAAAAAICAQGpUEhfrfOktzkAAAABgYCAHBqX
oG6NuMGTAACAgEBAAAAAICAQEAAAAAgIBAQAAAACAgEBAACAgEBAICAAAAAQEAgIAAAABAQCAgAA
AAGBgAAAAEBAICAAAADwlQgIAAAAQEAgIAAAABAQCAgAAAAEBAICAAAAAYGAAAAAwFciIAAAAAAB
UXwBMTs7S60CgLID2wUIiHW8KT9//jRXrlwx1dXVZufOnebAgQNmYGAgb59du3YV9fylGA1Zz2tK
Snu978d2iT4VI5+ldK82s05ulbwWw3Zt92eCe4aAiLwp3d3d5tGjR+bPnz92+ffv3+batWv2t1UN
c6lVSAQE+dzuAoJ8AgKiDG+Kog5hUYk9e/bkjvN/UWn56yRGLl++bHbv3m1qa2vN+Ph4bARCEY+q
qipTWVlpent787a9ePHCXuOOHTtMU1OTmZ6ezpRHf11cWsHrGx0dNXV1dXZfHfPy5ctV16z86T4N
DQ3FVjpt+/Llizl37pypqKgw7e3t5v3795HXLfGme6F9jx8/bo9Nuz3p3ocRl5f5+Xlz+vRpey7d
h4aGBvPs2bOCyicpraT7nub4T58+mebm5lXnXllZMfv27bN1O2092Mi8ZS03bXv48KGNHKou9PT0
mF+/fqV+FrLkM+75DCOqfnZ1dZlXr17lnVfPQti1PXjwwOZNdfLx48fm7t279t5EPYth1xdlu96+
fWv27t1r/u///i+xrmQt57h7uZb7XGi662nXEBAICNPY2Ghu375tIw9pj00yToODg+bWrVvWKH7/
/t0cPXo00niNjIzYSq199eDKcOp6fIHjKvnk5KTtYilUQMSlFbw+GQln+HSML7R0vX19fbn8HTly
JNHYHz582Hz79s0e8/TpU3P+/PnQc8tQ6sHVfvrp/kh4pN2edO+DJOVFBnZsbCx3Pp1bxreQ8klK
K+m+pzlenDhxYpVxVj4vXryYqR5sZN6ylpu2tbS02PR0jAy/uiILERBx+Ux6PoPE1c+vX7+aQ4cO
2fUSOzrPhw8fQq9Nz4fO9/z5c+vQVHZaDt63pOsLs10SW9pf15NUV7KWc9y9XMt9LjTd9bRrCAgE
hG0Jq8KpIp06dcrcv3/fvH79ek0CorW1NU+Q6BxRxktG0HWfOPwHQA/nkydPCs6jvy4ureD1BVv9
/nYnBqLyF5a2H3FQfpXvsLQPHjyYd+/0v1piabcn3fsgWfMi1HoppHyS0kq672mOFxMTE6atrS1v
P92X//77L1M92Mi8ZS03bXvz5k1ueXl52baaCxEQcflMej6DJNVPOUqJJTnHKMETvFdaXlpaKsh+
hNkuP+2kupK1nOPu5Vruc6HprqddQ0AgIHIorKcHWwpVYuLOnTsFC4hgt4gejLjWTzDU6D+QUtSu
tXXjxo01CYi4tJIGefrrggOzgvlLc13+PfK3+3kP2zdpe9K9D5ImL6ob169ft+Nl5CDS3tOoehaV
VtJ9z3K8wrSudStDKKeQtR5sZN6ylpu2BR1OVJ1KquNx+Ux6PuOcaVTedB6JisXFxVTPX9xy0vWl
sV1xdSVrOcfdy7Xc50LTXU+7hoBAQISiV5+SVHwWYxhXkeOMkf/AupaCQmyFCoi4tNbb2Mc57iz3
bq3bk4x7MC/qZ1c3l/qkp6ambNg37T0NkpRW0n3PcvzNmzfNpUuX7P8KoSuylrUebGTespZbFlGa
po5H5TPN8xlXn8LOpUin7lUxBETS9aWxXUl1JUs5J9WZtdznQtJdT7uGr0RA2MEywZaM0ECetA/h
wsLCqlCYH8acm5uLrMga9OOHJ+OYmZnJZFSD1xWXVpYHTf246iN0KNyZdF2uhePCulHhZt2PYAjY
FxtJ25PufZCkvKj/2S+fLPc0SFJaSfc9y/HKkwa6KSSrgWn+AMO09WAj85a13LRN1+T48eOHvYa0
z0LafGZ5PtPUz+HhYdvXLgcc14WRVgQkXV8aAZG2rhTzeVjLfc6S7nraNQQEAsKOmNbAp8+fP9tl
PTz37t2zA40cerjUd+YMgz9oR8ep28NPX4OMpOrdYBwNVIqqyDq3Gzymn5Y1ctshta9RxiI46Ces
9RN3XXFpZXnQgoONdL1Jxv7kyZO2xaVjlN+4QZS6/+5+yODW19en3p5074Mk5UXhXTfKXE5NRibt
PQ0LFcellXTfsx6v1uSZM2fy6nKWerCRectabtqmstK+Ouaff/4xHR0dqZ+FtPlMej6DxNVPtdY1
MM93mh8/flyTgEi6vqDtirqnUXUlaznH3cu13OdC011Pu4aAQEBYNIJbD7nCaOqblKjwWxEa8KRW
hGtJuEqq/XWcKm8wfY2hUFpS9Bo4FVeR+/v7rbJX+jJ0MjR+aE79jO61I/eghJF0XXFpZe2Ll7FX
3vTKnfIX98EaHat9tL/2k5gIDhILijpFgPSTYdOriVm2x937MOLyogG1bpCtDJUGa6W9p0GS0kq6
71mP1yBDrQt+jTBtPdjIvGUtN22TI6upqbGD6K5evWqjEGmfhSz5jHs+oxolYfWzs7Mz7zVO/a/0
1iIgkq4vaLui7mlUXclaznH3ci33udB019OuISAQEFAEFLXxuyTIS2kgA6wWI88zbOe6gi1AQGBw
Sgi1EjVgyb2zrRZX3AA78rLxKD9q0aV5e4LneXuz1evKdrcFCAgMTkmh0dd61UvhPQ1CVfhYDxx5
KR3U962uorgBceXMdp/jgbqCLUBAICAAAAAQEAgIAAAABAQCAgAAAAGBgAAAAAAEBAICAAAAAYGA
AAAAQECUyU3Z7sJiK+V/fHzcNDQ02K/R6Z1uzTXw8+dPLAIAAAICAQHh6LPGwemA9evq6uLmAAAg
INZHQGjyG33G1X1LXd/R1/frm5ubV+2vD4vo86Zq2epYTW+r1q6+e6+JaIIfY3HfxdfHWjQ5i5sD
Qo7N/y6+vt/e3t5u/5+fn7ffgtcxuh61qt0ENg7N36Fvtivt3t7eVXnSbH+6Ln0Q5fHjx3ZyGn1n
3p9kKHhf0py3VHGTL+m+uPupZeUFAAAQEOsiIE6dOpVz7P5sbnJK09PTeftrxraLFy/mjm1pabHH
6vOncl7+FL1y2kNDQ7kZ5jQ5iybXEfr2vGay03qJDk1Q46a8lnDR7ITuOKWhCYMcSkfX4T65qtC9
Js3x86TZLrXt+fPnVjjomrUcN1td0nlLGYkz5dN9OU5/lbf9+/djEQAAEBDrIyD8mSH9ffVd9La2
trxt+tSp5ol3+2kWO8fy8nLe5CuaIc6f1VP/KyrgC4HBwUHr/H3hEYaiIw6JFjl4HwmQqDxpeWlp
KfReJFUW/7zlhCI/yptmCwQAAATEugiIuHXq2nCRgffv31sB4e8XdOR+6z7M+frbnRiQqFhcXMxb
rylqr1+/brq7u60Q8a9JaQT7+v1zZZkOOLgt7rzlgrp0dN0SZwAAgIDYFAGh+eEvXbpk/1f3w/37
92OP9QVCUCyEHaPuk8bGxjwBoXEVWqdxDJrgRd0d/nFJUYFCBUTSeUudHz9+2IiRrvnOnTtYAgAA
BMTmCYjv37/bgXjfvn2zgxb9QZLab2ZmJs+BqR/e0dTUtKoLw59FcHh42I5lkMP2uzCUht/lsLCw
kHdNStffXiwBkXTeUhcPGsOh6y2XgZ//X3vnH2HV9v7xL0mSJJIkSYykmySSJEkkSa7ElSv9FUmS
JJIkSYwkSeLKlSRxXUmSSOaP5IokI1cuSZIkkiTJ+ngt3zXWrNl7/dhnz5wzM+8Xx8w5e++1nv2s
X++19rP3FkIICYgJLCDcysP27dvtXRbhfgTvITK4lHHs2DGzY8eOoe0EUXKHhwtKRDD09fXZbczu
165dO0wU/Pvvv/Z/Lpu4QXBwcNAGW/o2ke6ZM2eG0uU7dnQqIFL59jK8erfqNk7dpiuEEBIQXRMQ
BEry24sXL0bsx4A7b948e7cCgxgzYR93GycfhAi3h8LOnTuH3cbJ/9xCCQMDAzYokksgXFIgEDC0
6fjx43bFgBUNjkOQdCogcvLtVSgDCQghhJCA6LpTfBicmZ23maYQQgghATGBBQSXCJjtnzx5UgJC
CCGExkoJiDwIoNy0adOIJ0yCHxAphBBCSEDIKUIIIYQEhASEBIQQQgghASEBIYQQQkhASEAIIYQQ
EhASEEIIIYQEhASEEEIIobFSAkIIIYQQEhASEEIIIYQEhASEEEIIIQEhASGEEEJIQEhACCGEEBor
JSCEEEIIIQEhASGEEEJIQEhACCGEEBIQEhBCCCGEBMRkERAvXrxQrRpFn8i/8oF8JYQExLhzypcv
X8zBgwfNnDlzzNSpU83ixYvNqVOnhu0zbdq0rgqYXsyzDZ+MRlohd+/eteW6cuXKnq6ToQ/Gsr60
kddY+rmbvhortmzZolVTIQHR607ZtWuXuXbtmvn586f9/v37d3P06FH7abODmmidQZvnM5q+YVC7
d+/epPJnN/IeSz9P5IH15cuXZtOmTfYcJSCEBESPO4WOr2pVYvbs2UPH+Z+6tPzfECP79+83M2fO
NPPnzzc3btyw21+9emVWrFgx4tgfP36YBQsW2Hxz7PZ/czO/KVOmmOXLl5tHjx5V7sf/V69eNQsX
LrT7VnX4rLxgM+d+8eLFWp9V+cQdP2vWLDNjxgxz6NChyhlqaGdVWrFzqgKxR57Tp083GzZsMG/f
vo3a6YNg3L17tz12yZIl5vHjx1lp5/gs5XO/PlXVMeoD9eLbt28jbMYvOX4P6aRulpRhqt6mfFNX
Ljl5xcospx10u59avXq1BISQgBgPTlm6dKk5e/as7bByj011jufPnzdnzpyxnfWHDx/MunXrhrZv
3LhxxIBIh7Z3795su/3f/A7w/v379hJMXYe9bdu2oc6UY3zxhA1HjhwZsnnt2rXRihRuu3z5sk2D
4xl0GJjwa6mdqX1Dzp07Zwdu8uWDHQw8uY3hxIkT5tatW/b/O3fu2PqQm3bKZymfh/tW+Xffvn3W
Dh/ql7vMlvJ7SCd1s6QMcwREzDexconllVMfYvl2mx07dphPnz5JQAgJiPHglKdPn9qOkE5k69at
5sqVK2ZgYKAjAbFq1aphgoQ83HY6w82bNw87lv2fPXvWSEDMnTt3qKNNddjh7NnfvmbNGvP+/ftK
m3Ps4tq3uwzk8AeYXDtT+4YsW7ZsmK/5n3iW3MbAwBTanZt2ymcpn+cICJa0WQFwNvJ30aJFQ+mm
/B7SSd0sKcMcARHzTaxcYnnl1IdYvr3UX0lACAmIceKUJ0+e2NkZsxPERH9/f+POMZzR0BH621k+
ZWBwHTiddInd/m/MBPnOQHLy5MmswarqtzAwLbQ5ZRfnHC4vs0Rcamdq3xA/jyr/p8o9NvtMpZ3y
Wc4gmlPH1q9fb1cC4Pr167aO5vo9db4ldbOkDEvOPacN5ebVpD5IQAghAdGaU7hNrJPl2arOz99+
+vRpuzQNLK+y6tFUQDjx42aPLKm30WGXCojYoFViZ2rfHAGQOu9cAZFKO+WztgQEfiAOAIg9ePDg
QZHfS84pVTdzy7BbAqJJfZCAEEICopFTCH6rWiolCCu3c3z9+vWIywH+Murg4OCw7Vx7JsCL5W+C
38IguZK8fJ4/f549QIW/EbiFXQ6WrUsEBAPb58+fs8oiZmdq3xDyDZes/ZWBVGPo6+urXSpPpZ3y
WVsCwq0MsELG5Yumfm+zbqbKMFVvU76JlUssryb1QQJCCAmIRk4hYpvAqzdv3tjvdJgXLlwwBw4c
GNqHDpXrpq5j8oPJOI4lZT99lpmZyblANYLTwvyZ3W3fvn1YPnUzxlheXCsmOh5KgvTC38KAQKLX
YxUp9Ak+dMF5fPhOGjl2hmnF9g0hH8rL5Xvp0iU7+OQ2BoL1WJqHhw8fjgiijKWd8lmJgAh9EB5L
YCR3TYQBkim/h3RSN3PrWk69TfkmVi4xXzWpDxIQQkhANHYKEe10MiwHE3CFqPBnMXTazGLcTMZ1
nuzPcXSqYfrEUJAWszgiwcPt3JbGb6mn6qXyYkmZwDF3S5rr4EsFBDCwYC8DFTbHHvAU+gSOHz9u
bw/kNwaMd+/eZdkZphXbt04EsmLEh8GPWxJzGwOCcefOnTYf8uS6f27aKZ+VCIjQB+GxHz9+tNv8
FY8cv1fRtG7m1rWcepvyTaxcUr4qrQ8SEEJIQLTqlNGGTp5l6V6FDpzofzH5fNbrdVMIIQExaQUE
S6vMGlN3GIwlzEgJjnPPE2AWFwteFBPTZ71YN4UQEhASEP8P13B5XG0seHKsIbKfW/ZYFiaw9PDh
w3ZQFJPLZ71YN4UQEhASEEIIIYQEhASEEEIIIQEhpwghhBASEBIQEhBCCCGEBIQEhBBCCCEBIQEh
hBBCSEBIQAghhBASEHKKEEIIIQEhASEBIYQQQkhASEAIIYQQEhASEEIIIYQEhASEEEIIIQEhASGE
EEJorJSAEEIIIYQEhASEEEIIIQHRewLixYsXqlVCTBJ6pb2r3xESED3ulC9fvpiDBw+aOXPmmKlT
p5rFixebU6dODdtn2rRpXRUw4ynPMN8SG9qyV6tNnXP37l3bHlauXDlu2nVb5R62927Vpzb6ndH2
l9paPVu2bBmX/pGAKHDKrl27zLVr18zPnz/t9+/fv5ujR4/ajxra+DxXdWqdg3i4d+/epKxrvVJ/
xsO5qa2N5OXLl2bTpk3WNxIQE3xQo6OsWpWYPXv20HH+py4t/zfEyP79+83MmTPN/PnzzY0bN+z2
V69emRUrVow49sePH2bBggU23xy7/d/cTHHKlClm+fLl5tGjR7WzjatXr5qFCxfafasGCFZesJlz
v3jxYrQiIbR2795tpk+fbpYsWWIeP36cnOWkbPD3jaX/33//mW3bttltpMH2v//+O6sBsO2PP/6w
K06c582bN825c+fsedf5ZNasWWbGjBnm0KFDw7al7MgtmzpfPXnyxMydO9esWrUqy55YflUgkkkH
+zds2GDevn1bW+dLyj+WdmkZsO+ff/5p9yW9AwcOmG/fviXrWtP6k9PeU+cWq+O5ZVRXBrG8Q+r6
odJ+JNXWL1y4UHu+OW21rp7H+qJYO+iFsWb16tUSEJNBQCxdutScPXvWNpLcY1Od//nz582ZM2ds
A/7w4YNZt27d0PaNGzeO6DTocPbu3Zttt/+b32Dv379vL8HUda40ZNfhcIwvnrDhyJEjQzavXbs2
WpFOnDhhbt26Zf+/c+eO9WOOgIjZ4O8bSx8Rdv36dWsrHzoYOqBcAbFnzx4r2m7fvm07KXzP99Ce
y5cvW7+QB9vpgKkruXbklk2drxgsSffdu3dZ9sTyC2HAxl5nO2kzSOR2IrHyyUk7twzYl8so1BnS
YuDgkmOqrrVZf/zvOecWq+MlZRTakco7JNYPlfQjqba+devW2vPN8XVYz1N9UaoddJsdO3aYT58+
SUBMBgHx9OlT21io9DSEK1eumIGBgY4EBEraFyTk4bbTADdv3jzsWPZ/9uxZIwFBY3SNOzUghbMV
f/uaNWvM+/fvK22uE17usk8q31wb/P9j6VfB7CdXQIQzxs+fP1cey8AV2hDr8EM7cssm11cpe2L5
hSxbtmxYHeV/Zvm5nUisfHLSzi0D/vdnvF+/frWrdWNZf/zvpedW0l5TdSSVd0isHyqxK9XWY+eb
4+vw+FRf1KRddmvMkYCY4ALCwTIaip3ZA2Kiv7+/sYAIL4tQ2f3tLPdxncw1Dn/prnSgYbbgZmkn
T57MGpyrfgsDtkKbcy795AiI3H1j6bvyYmZEDAsda25wWKosQxvCpWS/80vZkVs2ub5K2RPLL9aJ
V/k81V5i5VOaduw7/4eDRV1ao1V//O9N/JZbJ1J1NZV3alvYpnPtym3rdb+VttVUX5TTLiUgJCC6
5hRun4otN5cKiHD76dOnzb59++z/LEGy6tFpA3UrGyz9NRm8U51NLwkIrokzK+I6+oMHD+zS52gI
iFSnlLIjt2xyfZXTSdbll1N+JRH6JQNXKu2UgMgdsEer/pS07U7aa+q4VN6dlkOdXZ0IiCZtNdUX
9aJYkICYpAKCIJ2q5TmCc3I7vNevX4+4HOAvHQ4ODg7bznU9gopYpiMQyA8KS9kd5uXz/PnzxoM3
QT/Y5eCSSqwi9fX1NbqEkbtvLH2umftL3qFP2hIQBJP5+ZTakVs2ueeQsieWX1Va4XK4P/NLdSKx
8ilNOyUgOBcH15bx+1jWn7BOlPott06kjkvlHZLqh3Ltym3rVb81aaupvqikHUhASECMqlOIaiY4
6c2bN/Y7gzlRxQT2OBjsuU7nGqMfcMRxXPbw0ydoiFUGFwRE4GSYPysP27dvH5ZP3Swilhfqnghq
iAUlphp6GLhEhHcqiJJlT3j48GF2EGWugIilzyUgF8lNp+gintsWENQLF4TGh+/4JdeOWNmkyrXq
HFL2xPKrSot67tK6dOmSHShyO5FY+ZSmnRIQnCN1krSOHTtmg9RGs/6E7T2sE6V+y60TIaEdqbxD
Uv1Qrl25bb3qtyZtNdUXpdqBBIQExJg6hchuGiJLYwQlISp85U6EL0rfqX3XwNif42h4YfrEUJAW
KwxEDYfbCQzjt9TT5lJ5sezIdUV3C5XrBJosrdLZYC+3fGFzbHaD0Nq5c6fNk/yJ5WhTQMTSJ8jV
Bb7SmRH8NRoCAo4fP25nUfiCQd5FiufYESubVLnWnUPMnlh+deKZlTY+CFpuM87tRGLlU5p2SkAw
AM2bN88G+h0+fNiuQoxm/Qnbe91tnLl+y60TIaEdqbyriPVDuXbltvWq35q21VRfFGsHEhASEF13
ymhDhUed9yp0Gn60uxBqt0J9kdqcBESXYdkNBZ2Kwh5LmKUQQOXurWamEwvwEkICQqgvUpuTgBhj
uLbJo05jwZNjDRHS3E7KkiCBpSwV03iF6Caj8T4I0duoL5KAkIAQQgghJCAkIIQQQgiNlRIQQggh
hJCAkIAQQgghJCAkIIQQQggJCAkIIYQQQgJCAkIIIYTQWCkBIYQQQggJCAkIIYQQQgJCAkIIIYSQ
gJCAEEIIISQgJCCEEEIICQg5RQghhJCAkICQgBBCCCEkICQghBBCCAmI8SEgXrx4oVolWmGi1CW1
CflG5aOxctILiC9fvpiDBw+aOXPmmKlTp5rFixebU6dODdtn2rRpXRUwvZgnabvPlClTzPTp083O
nTvNhw8fesI+yvXo0aNm3rx5tlwXLFhgv3/+/LmrtrVRl3xWr15t/v7778ptf/31l90+GvVpvLaJ
sbC17TLulg8/fvxoDh06ZObOnWvb0LJly8yNGzd6xvcl59523ZWAkICw7Nq1y1y7ds38/PnTfv/+
/bsdaPi02Ugn2iWU8HzwHwPWb7/91nWfUIbr1q0zZ86csZ2gs+/Jkydm06ZN2SJiPHT4pIdI+Pbt
2wgfrFixYtR8PNkuCTYdrMYrCPBVq1aZq1ev2roE//zzj1m0aJH5888/x52AmMx1VwJiFJ2Csq5q
PLNnzx4x03ZpVKXl/8ZgtX//fjNz5kwzf/58q9rZ/urVK9uph/z48cPOkMk3x27/t7t379pzYBVg
+fLl5tGjR5X78T+dwcKFC+2+HHPv3r1h6bLygs2c+8WLF6MVqW6br+5Ttueeh7Nt1qxZZsaMGXZW
FAPhcO7cucptdH4nTpyw/yN2Hj58OMyGLVu2VNr5xx9/2FUqfHPz5k2bPr6q82OVrXV1CWHDLO+X
X35pVD/6+/vNlStXhv2OKD558uSIMkAYYxcrRhs2bDBv377NriO+zeF55KTtzpOBabTrZ6fnmqq3
dcfW+SZWf1O2pNo49YL6USUi2b9JG6KNVLUhRIQrP/jvv//Mtm3brI+xccmSJcNWxKrKvdSWHAHR
ad0VEhCNnLJ06VJz9uzZIZWdc2xqYDx//rwdxBASLOkzG3bbN27cOGJwpOLv3bs3227/N7+h3L9/
316CqWtgNHTXiXKML56w4ciRI0M2r127tlhAcCwdQhMBETuPy5cvW/tIn8EUQUaZ1cEgXLfKwLmx
FAvv3r2zs3fSpfMlz5cvX1bauWfPHpv37du37SBGefE99GPK1qq6dODAAbs/9jSpH69fv7bl5bN5
82bz77//DsuPAYGBl7z4YOvu3buz60hd2eWm7Z/naNfPTs81VW9z/ZRbJ2Lp5bTxffv2jRjw6Yfc
5djSNkS/+ObNm2S/Slu7fv36kJ/xOWIhVu6ltuQKiKZ1V0hANHbK06dPbYOksm3dutXO5AYGBjoS
EChtX5CQh9t+584d27n7sP+zZ88aCQga661bt7IamD8DC7evWbPGvH//vtLmHLtc58HKSxMBETuP
lStXDl1icvidaGwVJLWdzoyOlg6MWJgc3/HdFyj+vilbq+qSn3bT+sGAimAAytGtZPj5IZz8esn/
rKrk1pFYJ9xG2m3Wz07t6aQthenk1IlYejltHOHLKoTLh79cbnDplrahmJhKwQpA7NxKbckVEE3r
rpCA6NgpLLMxkKBiaTwsCzcVEGHjo7H421lmczNdOkJ/aa9UQDAj4TuNkiXr3E4t/C0cdEObq471
PywrMwvyl9lLBETsPPBnmJ/fSXUiIFyHxuDi4iVSvot9T9maU5ea1I8LFy6YY8eODc083YzOT7/K
Z7GZc0kn3GbabdTPTu3pxNZwe2mdaNrG169fb2f2wKoAfVnTNsQliVzoO7nkQTwZwi3lq1JbcgVE
07orJCBadQq3+aRmjSUCItx++vRpO9gCy6rh9euSvFwDdjNXlnmbNLCU6Gniz9KOtu48Yp1L3YpF
VbwAfP36ddh1YWDliSXbNgREytacutSkfrA8TLwN5cb5c1mjtF520gm3mXYb9bNTe9o8l9I60bSN
s50YBKCOP3jwoHEbYgWr6o4qLjn4MQ7EFNF2iBEiP+phyleltlRNCCh/X+RIQEhAdMUpzJzD5TSI
XcsPv9NZh8ut/vLp4ODgsO00TCo/S7IEEoXBTyV5+Tx//ryo0fi/EQvgdxgsmbctIELbc8+DzrDk
zgmuBTMjr4LO7/jx40PfL126ZGdtdICxSxi5IiBla46AaFo/CBRkFYL6V2dbuKzfNOg13LfNtNuo
n53a06aAKK0TJW0j3I/VK1aguHxRYkMIKx1uNcOH4Fw/3oZ4ID/dnDZeagtixq3I+X0qQlkCQgKi
q04hUpsBxwUM0Vkz+BD44y/ncX3NdUh+UBPHsVTop8/yIbNIF/BFYFyYPzPL7du3D8unbiYVywv1
T5Q2lAYO+b+FQWoMRp0KiJTtuedB+bigVD58x746mCXhc8rRdVQcxx0X3GXx6dOnoVm73xnSsbk4
gqYCImVrWJfq/JhbP/zjiedgdscAUmcbPnG2IZ76+voadcLhebSZdhv1s1N7OrG1yjexOpFKL7eN
A5euWIkKgxJL2xBthMsR+I1VO3ebNhMuP0YMweJWJBjUEXopX5Xawgoc7dmtqnHnB7dj+wKnk7or
JCA6cgqRynQudL5cC0dU+JWLxsjsxc1gXCNmf46jcYfpE0NBWswg6djD7Y8fP7a/pZ6KlsqLpU0a
urt1yXU0TZZsET3YSweEzbFYgpxKlrI99zyAVQNmO9iEEHER3XUgBDmGDs49SIoByIkH4MFX/m2c
/O+uGzcVEClbw7pU58fc+uEfz7nhPz+/uts4+SBSuLW4SSccnkebabdRPzu1pxNbq3wTqxOp9HLb
OHAZjjyqLj+UtiFE/++//279R97E4vjtBRATLggdoUOwZ85sv9QWArRZVSEf/vK9ZBUnVT5CAqJV
p4w2NBgGt16FAZhBV6h+qH4KIQEhAdEjsGyHAg8jqrsJqyUEYbl7s5m9+cFaYnLXD9VPISQgJCB6
AK7BcQ0vFhw31hBBzRIly3pc5zx8+LDtqIXqh+qnEBIQEhBCCCGEkICQgBBCCCEkICQghBBCCAkI
CQghhBBCAkICQgghhNBYKQEhRGekHvIkhBASEJPAKTxhjX38F9CMhiBpQ8h0SwzxBDyeBOc/g77X
y9x/2x+3R/L0yaqn9DWh20+ya6sepNLh6YaHDh2yr5Wm/Hkq4o0bN7panuGn1ycKPEJdkxghATFB
nfLrr7/aB9Pw/oFeHsS7if9ui/FY5u55/r/99ltPDeC93DZ4qynPX+C9A+7x7v/88499nDBvYuy1
jq3XyoSXQPFMj1DoCCEBMUGcwmOD3WNx6Rh5C2I48Ozfv98+u53n8DP7Cmc9vM2Rp+XxkJubN2/a
F8Swfzjo+se5GT2zY17k9OjRo6xtde83YIbNS2l4UYy/L50/j0V2z9L37YnlE5v9ud94Tj8zUwaZ
XHtyfRXCS3R4bj7psi+vLvZfLZxb5uHKQczeOv9U+aOkzMLf6nzJe1rwDb7i+f91s20Gd973wDng
F96lkeu3WNs4ceKELZ8QRIRvZ04edefH+y3wP6scbQuIWNnm1NUqm0v7HfeCKQkIIQExAZ3CS3p4
DTLwCGE6NR/ebujeHsfy97p160Z05Hv27LFPxrt9+7bt8Pfu3Wu/x96e5w+Y9+/fty+lydkWvmGR
gcW92Y6XDDGQ+PvSsbuOMbQnlk/Kh3znbZHk616Gk2NPrq9CeK0vbzp1aZMPnXtJmXOc/6r2lL25
5VC6b5WACH0ZvoGSN4fWCQgGel5kBDzymRcb5fot1jZIx72pNkZOHuH54WvO0T2eGmEevkWyEwGR
KtucuhraXMqOHTvsS84kIIQExAR1CrNzZlDAK2NZhfBh9uG/nfPp06cjOvJw5uK/776u06eDdZ1+
SGybnwbXo33b+J/ZfZ1tJTbkCIgw7VJ7Yr7Kgdl+rr1uYGM1Kdfe3HIo3beqXoS+XLNmzbDVsKp6
5w/0nF8Tv8V8HhN0pXmE50csTWhzSsDG4h9K20aTttNJ/yMBISQgJphTmCmG76Ln3fN+MGXYidLp
NX3ds/8/efOdjjR8cVJsm59G1QBat+JRakOOgMgZ0GP25KTpw5Iys+1du3bZASD1Cmb/w2WAffv2
2ev6ufbmlkPpvrF64QgvtcTqXWqgj/kt5kOW9nMpzQObwzIqEYSpfVJl26TtSEAICQgJiCFY3q+a
1fB7rHNuQ0C4Tpcl582bN494u2DdttTAkeq4S2woHezb9FUIQXvMtImhQOCxrJwSEClS9uaWQ5N9
cwbYNgREym8xP3FpouquFS45+DEOTfKIiYU2BESqbJu0HQkIIQEhAWFheZLLF+EyKt/53S0fs5Ts
L3UODg62JiAcz58/z97m/0+wXrgM689ccwREjg25g32pPSUCgngJ/3IHl5s6FRApe3PLoXTf0Paq
tAi+8wfvZ8+e1R7T19dXewkj5bfYebCSQpxCyLVr12xMRid54Hv/mLYFRKpsm7QdCQghASEBMdQ5
VkWYQ39//1AwJcFhBFq6YDYucbQhIJixEbkPYQBhbFsYKHbhwoWhQLBLly7ZwSRXQMTyaSIgSu0p
ERCIOjfrRcS56PZOGkLK3ph/WN5HhLpBKLavH2BJUKJb+YrZGgZRcqktFkTJJRTgmSZ+EGXKbzE/
EQDI5Qj88vXr16FbYbkcNDAw0FEe+N4FJ/Phe3g5sRMBkSrbJm1HAkJIQEhAWFie/fbtW+X+dJbM
UHxBQYAVt5wRrd2GgGC5m87Z3V7pBp/Utrpb1fgQRf7q1atsARHLp4mAKLWnREAwYBFkh50MkAQs
diogUvbG/MMdA8xY3aw1tq8TFGxjkGJbziCOcKXOcfsw9a5uhkw95iFZ7kFPBFzm+i3lJwTP77//
bv2D/QQVI1JKyqYuD+56YvWC80JUxe526OQ2zqqybdJ2JCCEBIQEhBDjDkSCe16JEEJIQEhACFEJ
K14EZLrnJDBbjgW5CiGEBIQEhBD2bgYuF7C8T8zB4cOHrZAQQggJCAkIIYQQQgJCAkIIIYSQgJCA
EEIIISQgJCCEEEIIIQEhASGEEEJIQEhACCGEEBIQEhBCCLVoUHcAAABcSURBVCGEBIQEhBBCCKGx
UgJCCCGEEBIQEhBCCCGEBIQEhBBCCCEBIQEhhBBCSEBIQAghhBASEHKMEEIIIfFQfIwcJIQQQkg8
SEBkOEofffTRRx999Pm/jibW/wPtUIy69ZfluwAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-03-14 10:15:09 +0000" MODIFIED_BY="Jane Cracknell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0YAAAGWCAMAAABrW2MsAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2014-03-14 10:15:09 +0000" MODIFIED_BY="Jane Cracknell" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAe0AAALTCAIAAAC0Ts3sAAAsxUlEQVR42u3dsW4Uyb7H8ZGQEIED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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">
<APPENDIX ID="APP-01" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="1">
<TITLE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">Search strategy for CENTRAL</TITLE>
<APPENDIX_BODY MODIFIED="2009-01-12 12:29:21 +0000" MODIFIED_BY="Karen Hovhannisyan">
<P>#1 (operation or peri?op* or post?op* or intra?op* or surg*):ti,ab<BR/>#2 (pulse near ox?met*)<BR/>#3 MeSH descriptor Oximetry explode all trees<BR/>#4 (#1 AND ( #2 OR #3 ))<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2009-01-12 12:30:26 +0000" MODIFIED_BY="Karen Hovhannisyan" NO="2">
<TITLE MODIFIED="2009-01-12 12:27:38 +0000" MODIFIED_BY="Karen Hovhannisyan">Search strategy for MEDLINE (Ovid SP)</TITLE>
<APPENDIX_BODY MODIFIED="2009-01-12 12:30:26 +0000" MODIFIED_BY="Karen Hovhannisyan">
<P>1 (operation or perioperat* or postoperat* or intraoperat* or surg*).mp.<BR/>2 ((pulse adj6 oximet*) or (pulse adj6 oxymet*)).mp. or exp Oximetry/ or oxymet*.ti,ab.<BR/>3 ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) and humans.sh.<BR/>4 1 and 3 and 2</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2009-01-12 12:31:55 +0000" MODIFIED_BY="Karen Hovhannisyan" NO="3">
<TITLE MODIFIED="2009-01-12 12:27:51 +0000" MODIFIED_BY="Karen Hovhannisyan">Search strategy for EMBASE (Ovid SP)</TITLE>
<APPENDIX_BODY MODIFIED="2009-01-12 12:31:55 +0000" MODIFIED_BY="Karen Hovhannisyan">
<P>1 (operation or perioperat* or postoperat* or intraoperat* or surg*).mp. <BR/>2 exp Pulse Oximetry/ or exp Oximetry/ <BR/>3 ((pulse adj6 oximet*) or (pulse adj6 oxymet*) or oxymet* or oximet*).mp. <BR/>4 3 or 2 <BR/>5 (placebo.sh. or controlled study.ab. or "random*".ti,ab. or trial*.ti.) and human*.ec,hw,fs. <BR/>6 1 and 4 and 5 </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell" NO="4">
<TITLE MODIFIED="2014-03-14 10:15:07 +0000" MODIFIED_BY="Jane Cracknell">Search strategy for CINAHL (EBSCO host)</TITLE>
<APPENDIX_BODY MODIFIED="2009-01-12 12:35:14 +0000" MODIFIED_BY="Karen Hovhannisyan">
<P>S1 TX (operation or perioperat* or postoperat* or intraoperat* or surg*)<BR/>S2 (MH "Perioperative Care+")<BR/>S3 (MH "Postoperative Care+")<BR/>S4 (MH "Intraoperative Care+") or (MH "Intraoperative Monitoring+")<BR/>S5 S4 or S3 or S2 or S1<BR/>S6 (MM "Pulse Oximeters") or (MM "Pulse Oximetry")<BR/>S7 TX (pulse and ox?met*)<BR/>S8 S7 or S6<BR/>S9 S8 and S5<BR/>S10 (MM "Random Assignment") or (MH "Clinical Trials+")<BR/>S11 AB random*<BR/>S12 TI trial<BR/>S13 AB placebo<BR/>S14 S13 or S12 or S11 or S10<BR/>S15 S14 and S9</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2009-01-12 12:35:45 +0000" MODIFIED_BY="Karen Hovhannisyan" NO="5">
<TITLE MODIFIED="2009-01-12 12:28:32 +0000" MODIFIED_BY="Karen Hovhannisyan">Search strategy for ISI Web of Science</TITLE>
<APPENDIX_BODY MODIFIED="2009-01-12 12:35:45 +0000" MODIFIED_BY="Karen Hovhannisyan">
<P># 1 TS=(operation or perioperat* or postoperat* or intraoperat* or surg*)<BR/># 2 TS=((pulse SAME oximet*) or (pulse SAME oxymet*) or oxymet*)<BR/># 3 #2 AND #1<BR/># 4 TS=(random* or ((controlled or clinical) SAME trial*) or placebo)<BR/># 5 #4 AND #3</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2009-01-12 12:36:49 +0000" MODIFIED_BY="Karen Hovhannisyan" NO="6">
<TITLE MODIFIED="2009-01-12 12:29:04 +0000" MODIFIED_BY="Karen Hovhannisyan">Search strategy for LILACS (BIREME)</TITLE>
<APPENDIX_BODY MODIFIED="2009-01-12 12:36:49 +0000" MODIFIED_BY="Karen Hovhannisyan">
<P>("OXYMETER" or "OXYMETRY" or "puls oximet$") and (operation or perioperat$ or postoperat$ or intraoperat$ or surg$) </P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Included studies&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 5 trials&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Number of trials by outcome:&lt;/p&gt;&lt;p&gt;Studies using blood gas analysis and pulse oximetry assessing hypoxaemia&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;b&gt;2&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Study using tests of cognitive dysfunction&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;b&gt;1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Study using clinical measures of complications to discharge&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&lt;b&gt;1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;span&gt;Study using Pulse Oximetry Monitoring on Intensive Care Unit Admissions from a Postsurgical Care Floor&amp;#160;&amp;#160;&amp;#160;&lt;b&gt;1&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;" WIDTH="450">
<FLOWCHARTBOX TEXT="&lt;p&gt;Full-text articles assessed for eligibility 8&lt;/p&gt;" WIDTH="104">
<FLOWCHARTBOX TEXT="&lt;p&gt;Records screened &lt;b&gt;1293&lt;/b&gt;&lt;/p&gt;" WIDTH="102">
<FLOWCHARTBOX TEXT="&lt;p&gt;Duplicates removed&lt;b&gt; 431&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Database search 1724&lt;/b&gt;&lt;/p&gt;&lt;p&gt;CENTRAL&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;354&lt;br&gt;MEDLINE&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;451&lt;br&gt;EMBASE&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;516&lt;br&gt;CINAHL&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;91&lt;br&gt;Web of Science&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;299&lt;br&gt;LILACS&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;13&lt;/p&gt;" WIDTH="295"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Other sources &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 2&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Reference lists of trials&amp;#160;&amp;#160;&amp;#160;2&lt;/p&gt;" WIDTH="167"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;Records excluded &lt;b&gt;1285&lt;/b&gt;&lt;/p&gt;" WIDTH="113"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;Full-text articles excluded, with reasons &lt;b&gt;2&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Full-text articles awaiting assessment 1&lt;/b&gt;&lt;/p&gt;" WIDTH="113"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>